UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM
10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended May 2, 2020

1, 2021

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from
to

Commission file number
0-13200

AstroNova, Inc.

(Exact name of registrant as specified in its charter)

Rhode Island
 
05-0318215

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

600 East Greenwich Avenue, West Warwick, Rhode Island
 
02893
(Address of principal executive offices)
 
(Zip Code)

(401)
828-4000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol

 

Name of each exchange

on which registered

Common Stock, $.05 Par Value
 
ALOT
 
NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes
  ☒    No  ☐.

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes
  ☒    No  ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.

Large accelerated filer   Accelerated filer 
Non-accelerated
filer
   Smaller reporting company 
 
  Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act)    Yes  ☐    No  ☒.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

The number of shares of the registrant’s common stock, $.05 par value per share, outstanding as of June 23, 20208, 2021 was 7,163,293.

7,231,068.


EXPLANATORY NOTE

As previously disclosed in our Current Report on Form8-K filed with the SEC on June 11, 2020, the filingTable of this Quarterly Report on Form10-Q for the period ended May 2, 2020 (the “Quarterly Report”) was delayed due to the significant disruptions to our business and operations as a result of theCOVID-19 pandemic. In particular, many of our key finance and accounting personnel, as well as our accounting advisors, are working remotely as a result of social distancing measures put in place in response to COVID-19, and this caused significant inefficiencies in the processes relating to the preparation of this Quarterly Report. The impact ofCOVID-19 on our business also necessitated additional analysis in connection with the preparation and review of the Quarterly Report, including with regard to our available liquidity and capital resources and the impact of theCOVID-19 crisis on goodwill and intangible asset impairment. We relied on the Securities and Exchange Commission’s order issued on March 4, 2020 and revised on March 25, 2020 (ReleaseNo. 34-88465) pursuant to Section 36 of the Securities Exchange Act of 1934, as amended, to delay the filing of this Quarterly Report.

Contents


2

Part I. FINANCIAL INFORMATION

Item 1.

Financial Statements

ASTRONOVA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Share Data)

   May 2,
2020
  January 31,
2020
 
   (Unaudited)    
ASSETS   

CURRENT ASSETS

   

Cash and Cash Equivalents

  $11,091  $4,249 

Accounts Receivable, net

   18,473   19,784 

Inventories, net

   32,557   33,925 

Prepaid Expenses and Other Current Assets

   2,489   2,193 
  

 

 

  

 

 

 

Total Current Assets

   64,610   60,151 

Property, Plant and Equipment, net

   11,377   11,268 

Intangible Assets, net

   24,328   25,383 

Goodwill

   11,988   12,034 

Deferred Tax Assets, net

   5,073   5,079 

Right of Use Assets

   1,553   1,661 

Other Assets

   1,071   1,088 
  

 

 

  

 

 

 

TOTAL ASSETS

  $120,000  $116,664 
  

 

 

  

 

 

 
LIABILITIES AND SHAREHOLDERS’ EQUITY   

CURRENT LIABILITIES

   

Accounts Payable

  $4,282  $4,409 

Accrued Compensation

   2,893   2,700 

Other Accrued Expenses

   3,697   4,711 

Revolving Credit Facility

   11,500   6,500 

Current Portion of Long-Term Debt

   6,602   5,208 

Current Liability – Royalty Obligation

   2,000   2,000 

Current Liability – Excess Royalty Payment Due

   586   773 

Deferred Revenue

   375   466 
  

 

 

  

 

 

 

Total Current Liabilities

   31,935   26,767 

Long-Term Debt, net of current portion

   6,334   7,715 

Royalty Obligation, net of current portion

   7,550   8,012 

Lease Liabilities, net of current portion

   1,199   1,279 

Deferred Tax Liabilities

   378   435 

Other Long-Term Liabilities

   1,042   1,081 
  

 

 

  

 

 

 

TOTAL LIABILITIES

   48,438   45,289 

SHAREHOLDERS’ EQUITY

   

Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 10,371,704 shares and 10,343,610 shares at May 2, 2020 and January 31, 2020, respectively

   518   517 

AdditionalPaid-in Capital

   56,656   56,130 

Retained Earnings

   49,233   49,298 

Treasury Stock, at Cost, 3,287,271 and 3,281,701 shares at May 2, 2020 and January 31, 2020, respectively

   (33,531  (33,477

Accumulated Other Comprehensive Loss, net of tax

   (1,314  (1,093
  

 

 

  

 

 

 

TOTAL SHAREHOLDERS’ EQUITY

   71,562   71,375 
  

 

 

  

 

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

  $120,000  $116,664 
  

 

 

  

 

 

 

   
May 1,

2021
  
January 31,

2021
 
   
(Unaudited)
    
ASSETS
       
CURRENT ASSETS
         
Cash and Cash Equivalents
  $11,414  $11,439 
Accounts Receivable, net
   15,249   17,415 
Inventories, net
   29,474   30,060 
Prepaid Expenses and Other Current Assets
   2,072   1,807 
          
Total Current Assets
   58,209   60,721 
Property, Plant and Equipment, net
   12,124   12,011 
Intangible Assets, net
   20,496   21,502 
Goodwill
   12,730   12,806 
Deferred Tax Assets
   5,944   5,941 
Right of Use Assets
   1,302   1,389 
Other Assets
   1,251   1,103 
          
TOTAL ASSETS
  $112,056  $115,473 
          
LIABILITIES AND SHAREHOLDERS’ EQUITY
       
CURRENT LIABILITIES
         
Accounts Payable
  $5,639  $5,734 
Accrued Compensation
   2,951   2,852 
Other Liabilities and Accrued Expenses
   3,448   3,939 
Current Liability – Royalty Obligation
   2,000   2,000 
Current Portion of Long-Term Debt
  
813
   
5,326
 
Current Liability – Excess Royalty Payment Due
   —     177 
Deferred Revenue
  
330
   
285
 
Income Taxes Payable
   260   655 
          
Total Current Liabilities
   15,441   20,968 
Long-Term Debt, net of current portion
   8,884   7,109 
Royalty Obligation, net of current portion
   5,711   6,161 
Long-Term Debt – PPP Loan
   4,422   4,422 
Lease Liabilities, net of current portion
   983   1,065 
Other Long-Term Liabilities
   680   681 
Deferred Tax Liabilities
   402   384 
          
TOTAL LIABILITIES
   36,523   40,790 
SHAREHOLDERS’ EQUITY
         
Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 10,479,139 shares and 10,425,094 shares at May 1, 2021 and January 31, 2021, respectively
   524   521 
Additional
Paid-in
Capital
   58,576   58,049 
Retained Earnings
   50,678   50,085 
Treasury Stock, at Cost, 3,312,687 and 3,297,058 shares at May 1, 2021 and January 31, 2021, respectively
   (33,796  (33,588
Accumulated Other Comprehensive Loss, net of tax
   (449  (384
          
TOTAL SHAREHOLDERS’ EQUITY
   75,533   74,683 
          
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
  $112,056  $115,473 
          
See Notes to condensed consolidated financial statements (unaudited).

3

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In Thousands, Except Per Share Data)

(Unaudited)

   Three Months Ended 
   May 2,
2020
  May 4,
2019
 

Revenue

  $30,919  $36,181 

Cost of Revenue

   20,064   21,942 
  

 

 

  

 

 

 

Gross Profit

   10,855   14,239 

Operating Expenses:

   

Selling and Marketing

   5,925   6,765 

Research and Development

   1,940   2,007 

General and Administrative

   2,327   2,999 
  

 

 

  

 

 

 

Operating Expenses

   10,192   11,771 
  

 

 

  

 

 

 

Operating Income

   663   2,468 

Other Expense, net

   (349  (368
  

 

 

  

 

 

 

Income Before Income Taxes

   314   2,100 

Income Tax (Benefit) Provision

   (118  400 
  

 

 

  

 

 

 

Net Income

  $432  $1,700 
  

 

 

  

 

 

 

Net Income Per Common Share—Basic:

  $0.06  $0.24 
  

 

 

  

 

 

 

Net Income Per Common Share—Diluted:

  $0.06  $0.23 
  

 

 

  

 

 

 

Weighted Average Number of Common Shares Outstanding:

   

Basic

   7,073   6,971 

Diluted

   7,105   7,248 

  
Three Months Ended
 
 
  
May 1,
2021
 
 
May 2,
2020
 
Revenue
  $29,078  $30,919 
Cost of Revenue
   18,190   20,064 
Gross Profit
   10,888   10,855 
Operating Expenses:
         
Selling and Marketing
   6,092   5,925 
Research and Development
   1,717   1,940 
General and Administrative
   2,344   2,327 
Operating Expenses
   10,153   10,192 
Operating Income
   735   663 
Other Expense, net
   369   349 
Income Before Income Taxes
   366   314 
Income Tax Benefit
   (227  (118
Net Income
  $593  $432 
Net Income per Common Share—Basic:  $0.08  $0.06 
Net Income per Common Share—Diluted:  $0.08  $0.06 
Weighted Average Number of Common Shares Outstanding:
         
Basic
   7,145   7,073 
Diluted
   7,265   7,105 
See Notes to condensed consolidated financial statements (unaudited).

4

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Thousands)

(Unaudited)

   Three Months
Ended
 
   May 2,
2020
  May 4,
2019
 

Net Income

  $432  $1,700 

Other Comprehensive Loss, Net of Taxes

   

Foreign Currency Translation Adjustments

   (142  (172

Change in Value of Derivatives Designated as Cash Flow Hedge

   (46  116 

(Gains) Losses from Cash Flow Hedges Reclassified to Income Statement

   (33  (144
  

 

 

  

 

 

 

Other Comprehensive Loss

   (221  (200
  

 

 

  

 

 

 

Comprehensive Income

  $211  $1,500 
  

 

 

  

 

 

 

  
Three Months Ended
 
 
  
May 1,
2021
 
 
May 2,
2020
 
Net Income
  $593  $432 
Other Comprehensive
Loss, Net of Taxes:
         
Foreign Currency Translation Adjustments
   (81  (142
Change in Value of Derivatives Designated as Cash Flow Hedge
   —     (46
Loss (Gain) from Cash Flow Hedges Reclassified to Income Statement
   16   (33
Other Comprehensive
 
Loss
   (65  (221
Comprehensive Income
  $528  $211 
See Notes to condensed consolidated financial statements (unaudited).

5

ASTRONOVA, INC.

CONDENSED

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

($ In Thousands, Except per Share Data)

(Unaudited)

   Common Stock   Additional
Paid-in
Capital
  Retained
Earnings
  Treasury
Stock
  Accumulated
Other
Comprehensive
Income (Loss)
  Total
Shareholders’
Equity
 
   Shares   Amount 

Balance February 1, 2019

   10,218,559   $511   $53,568  $49,511  $(32,997 $(818 $69,775 

Share-Based Compensation

   —      —      601   —     —     —     601 

Employee Option Exercises

   27,990    1    306   —     (11  —     296 

Restricted Stock Awards Vested, net

   9,522    1    (1  —     (69  —     (69

Cash Dividend—$0.07 per share

   —      —      —     (489  —     —     (489

Net Income

   —      —      —     1,700   —     —     1,700 

Other Comprehensive Loss

   —      —      —     —     —     (200  (200
  

 

 

   

 

 

   

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balance May 4, 2019

   10,256,071   $513   $54,474  $50,722  $(33,077 $(1,018 $71,614 
  

 

 

   

 

 

   

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

   Common Stock   Additional
Paid-in
Capital
  Retained
Earnings
  Treasury
Stock
  Accumulated
Other
Comprehensive
Income (Loss)
  Total
Shareholders’
Equity
 
   Shares   Amount 

Balance February 1, 2020

   10,343,610   $517   $56,130  $49,298  $(33,477 $(1,093 $71,375 

Share-Based Compensation

   —      —      495   —     —     —     495 

Employee Option Exercises

   4,456    —      32   —     —     —     32 

Restricted Stock Awards Vested, net

   23,638    1    (1  —     (54  —     (54

Cash Dividend—$0.07 per share

   —      —      —     (497  —     —     (497

Net Income

   —      —      —     432   —     —     432 

Other Comprehensive Loss

   —      —      —     —     —     (221  (221
  

 

 

   

 

 

   

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balance May 2, 2020

   10,371,704   $518   $56,656  $49,233  $(33,531 $(1,314 $71,562 
  

 

 

   

 

 

   

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

(Unaudited)

   Three Months Ended 
   May 2,
2020
  May 4,
2019
 

Cash Flows from Operating Activities:

   

Net Income

  $432  $1,700 

Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:

   

Depreciation and Amortization

   1,568   1,584 

Amortization of Debt Issuance Costs

   12   13 

Share-Based Compensation

   495   601 

Changes in Assets and Liabilities:

   

Accounts Receivable

   1,220   1,439 

Inventories

   1,237   (2,001

Income Taxes

   (90  263 

Accounts Payable and Accrued Expenses

   (1,140  (2,796

Other

   (314  184 
  

 

 

  

 

 

 

Net Cash Provided by Operating Activities

   3,420   987 

Cash Flows from Investing Activities:

   

Additions to Property, Plant and Equipment

   (626  (586
  

 

 

  

 

 

 

Net Cash Used by Investing Activities

   (626  (586

Cash Flows from Financing Activities:

   

Net Cash Proceeds from Employee Stock Option Plans

   6   270 

Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan

   26   26 

Net Cash Used for Payment of Taxes Related to Vested Restricted Stock

   (54  (69

Borrowings under Revolving Credit Facility

   5,000   —   

Payment of Minimum Guarantee Royalty Obligation

   (500  (375

Principal Payments of Long-Term Debt

   —     (1,578

Dividends Paid

   (497  (489
  

 

 

  

 

 

 

Net Cash Provided (Used) by Financing Activities

   3,981   (2,215
  

 

 

  

 

 

 

Effect of Exchange Rate Changes on Cash and Cash Equivalents

   67   49 
  

 

 

  

 

 

 

Net Increase (Decrease) in Cash and Cash Equivalents

   6,842   (1,765

Cash and Cash Equivalents, Beginning of Period

   4,249   7,534 
  

 

 

  

 

 

 

Cash and Cash Equivalents, End of Period

  $11,091  $5,769 
  

 

 

  

 

 

 

Supplemental Disclosures of Cash Flow Information:

   

Cash Paid During the Period for Interest

  $124  $110 

Cash Paid During the Period for Income Taxes, Net of Refunds

  $128  $142 

Schedule ofNon-Cash Financing Activities:

   

Value of Shares Received in Satisfaction of Option Exercise Price

  $—    $11 

   
Common Stock
   
Additional
Paid-in
  
Retained
  
Treasury
  
Accumulated
Other
Comprehensive
  
Total
Shareholders’
 
   
Shares
   
Amount
   
Capital
  
Earnings
  
Stock
  
Income (Loss)
  
Equity
 
Balance January 31, 2020   10,343,610   $517   $56,130  $49,298  $(33,477 $(1,093 $71,375 
Share-Based Compensation   —      —      495   —     —     —     495 
Employee Option Exercises
   4,456    —      32   —     —     —     32 
Restricted Stock Awards Vested, net
   23,638    1    (1  —     (54  —     (54
Common Stock – Cash Dividend - $0.07 per
 
share
   —      —      —     (497  —     —     (497
Net Income
   —      —      —     432   —     —     432 
Other Comprehensive Loss
   —      —      —     —     —     (221  (221
                                
Balance May 2, 2020
   10,371,704   $518   $56,656  $49,233  $(33,531 $(1,314 $71,562 
                                
   
Common Stock
   
Additional
Paid-in
  
Retained
   
Treasury
  
Accumulated
Other
Comprehensive
  
Total
Shareholders’
 
   
Shares
   
Amount
   
Capital
  
Earnings
   
Stock
  
Income (Loss)
  
Equity
 
Balance January 31, 2021   10,425,094   $521   $58,049  $50,085   $(33,588 $(384 $74,683 
Share-Based Compensation
   —      —      478   —      —     —     478 
Employee Option Exercises
   5,746    —      52   —      —     —     52 
Restricted Stock Awards Vested, net
   48,299    3    (3  —      (208  —     (208
Net Income
   —      —      —     593    —     —     593 
Other Comprehensive Loss
   —      —      —     —      —     (65  (65
                                 
Balance May 1, 2021
   10,479,139   $524   $58,576  $50,678   $(33,796 $(449 $75,533 
       ��                         
See Notes to condensed consolidated financial statements (unaudited).

6

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In Thousands)
(Unaudited)
   
Three Months Ended
 
   
May 1,

2021
  
May 2,

2020
 
Cash Flows from Operating Activities:
         
Net Income
  $593  $432 
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:
         
Depreciation and Amortization
   1,425   1,568 
Amortization of Debt Issuance Costs
   25   12 
Share-Based Compensation
   478   495 
Changes in Assets and Liabilities:
         
Accounts Receivable
   2,165   1,220 
Inventories
   568   1,237 
Income Taxes
   (387  (90
Accounts Payable and Accrued Expenses
   (552  (1,140
Other
   (406  (314
          
Net Cash Provided by Operating Activities
   3,909   3,420 
Cash Flows from Investing Activities:
         
Additions to Property, Plant and Equipment
   (544  (626
          
Net Cash Used for Investing Activities
   (544  (626
Cash Flows from Financing Activities:
         
Net Cash Proceeds from Employee Stock Option Plans
   34   6 
Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan
   18   26 
Net Cash Used for Payment of Taxes Related to Vested Restricted Stock
   (208  (54
Borrowings under Revolving Credit Facility
   —     5,000 
Payment of Minimum Guarantee Royalty Obligation
   (500  (500
Proceeds from Long-Term Debt Borrowings
   10,000   —   
Payoff of Long-Term Debt
   (12,576  —   
Principal Payments on Long-Term Debt
   (187  —   
Dividends Paid
   —     (497
          
Net Cash Provided by (Used) for Financing Activities
   (3,419  3,981 
          
Effect of Exchange Rate Changes on Cash and Cash Equivalents
   29   67 
          
Net Increase (Decrease) in Cash and Cash Equivalents
   (25  6,842 
Cash and Cash Equivalents, Beginning of Period
   11,439   4,249 
          
Cash and Cash Equivalents, End of Period
  $11,414  $11,091 
          
Supplemental Disclosures of Cash Flow Information:
         
Cash Paid During the Period for Interest
  $115  $124 
Cash Paid During the Period for Income Taxes, Net of Refunds
  $131  $128 
See Notes to condensed consolidated financial statements (unaudited).
7

ASTRONOVA, INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 1 – Business and Basis of Presentation

Overview

Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad ranger
a
nge of specialty printers and data acquisition and analysis systems. Our products are employed around the world in a wide range of applications in the aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation industries. In the United States, we have factory-trained direct field salespeople located in major cities from coast to coast. We also have direct field sales or service centers in Canada, China, Denmark, France, Germany, Malaysia, Mexico, Singapore, and the United Kingdom staffed by our own employees and dedicated third-party contractors. Additionally, we utilize over 225 independent dealers and representatives selling and marketing our products in over 60 countries.

industries

Our business consists of two2
 segments, Product Identification (“PI”) and Test & Measurement (“T&M”). The PI segment includes specialty printing systems and related supplies sold under the QuickLabel®, TrojanLabel® and GetLabels™ brand names QuickLabel®, TrojanLabel® and GetLabels.names. The T&M segment includes our line of aerospace flight deck printers and test and measurement data acquisition systems sold under the AstroNova®AstroNova® brand name.

PI products sold under the QuickLabel, TrojanLabel and GetLabels brands are used in brand owner and commercial applications to provide product packaging, marketing, tracking, branding and labeling solutions to a wide array of industries. The PI segment offers a variety of digital color label tabletop printers, high-volume presses and specialty original equipment manufacturer (“OEM”) printing systems, as well as a wide range of label, tag and flexible packaging material substrates and other supplies, including ink and toner, that allowallowing customers to mark, track, protect and enhance the appearance of their products. In the T&M segment, we have a long history of using our technologies to provide networking systems and high-resolution light-weight flight deck and cabin printers for the aerospace market. In addition, the T&M segment includes data acquisition recorders, sold under the AstroNova brand, to enable our customers to acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats.

Our Product Identification products are sold by direct field salespersons as well as independent dealers and representatives, while our Test & Measurement products are sold predominantly through direct sales and manufacturers’ representatives. In the United States, we have factory-trained direct field salespeople located throughout the country specializing in Product Identification products. We also have direct field sales or service centers in Canada, China, Denmark, France, Germany, Malaysia, Mexico, Singapore, and the United Kingdom staffed by our own employees and dedicated third party contractors. Additionally, we utilize over 200 independent dealers and representatives selling and marketing our products in over 60 countries.
Unless otherwise indicated, references to “AstroNova,“AstroNova”, “we,” “our,” and “us” in this Quarterly Report on
Form 10-Q
refer to AstroNova, Inc. and its consolidated subsidiaries.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with our Annual Report on Form
10-K
for the fiscal year ended January 31, 2020.

2021.

The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes, , including those that require consideration of forecasted financial information, in context of the unknown future impacts of
COVID-19
using information that is reasonably available to us at this time. Some of the more significant estimates relate to revenue recognition, the allowances for doubtful accounts, inventory valuation, income taxes, impairment of long-lived assets and goodwill, share-based compensation, accrued expenses, self-insurance liability accrual and warranty reserves. Management’s estimates are based on the facts and circumstances available at the time estimates are made, historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters, including our expectations at the time regarding the duration, scope and severity of the
COVID-19
pandemic. Consequently, actual results could differ from those estimates.

Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year.

Certain amounts in the prior year financial statements have been reclassified to conform to the current year’s presentation.

8

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of AstroNova, Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Note 2 – Summary of Significant Accounting Policies Update

The accounting policespolicies used in preparing the condensed consolidated financial statements in this Form
10-Q
are the same as those used in preparing our consolidated financial statements as of and for the year ended January 31, 2020 and included in our Annual Report on Form
10-K
for the fiscal year ended January 31, 2020.

2021.

Recently Adopted Accounting Pronouncements

Fair Value Measurement

Income Taxes
In August 2018,December 2019, the FinancialFASB issued an ASU
2019-12,
“Simplifying the Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”)2018-13, “Fair Value Measurement (Topic 820), Disclosure Framework-Changesfor Income Taxes,” which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. ASU
2019-12
is effective for fiscal years beginning after December 15, 2020. Most amendments within the Disclosure Requirements for Fair Value Measurement.” ASU2018-13 modifies the disclosure requirements for fair value measurements by removing, modifying or adding certain disclosures. The provisions of ASU2018-13 relatingstandard are required to changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. The remaining provisions shouldon a prospective basis, while certain amendments must be applied retrospectively to all periods presented upon their effective date.on a retrospective or modified retrospective basis. We adopted ASU
2019-12
for the provisions of this guidance effectiveperiod beginning February 1, 2020.2021. The adoption of this guidance did not have a material impact on our consolidated financial statements and relatedaccompanying disclosures.

Recent Accounting Standards Not Yet Adopted

Reference Rate Reform

In March 2020, the FASB issued ASU2020-04, “Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” ASU2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) or by another reference rate expected to be discontinued. The amendments are effective for all entities as of March 12, 2020 through December 31, 2022. We are currently in the process of evaluating the impact of the transition from LIBOR to an alternative reference rate, but we do not expect that to have a material impact on our consolidated financial statements.

No other new accounting pronouncements, issued or effective during the first three months of the current fiscal year, have had or are expected to have a material impact on our consolidated financial statements.

Note 3 – Revenue Recognition

We derive revenue from the sale of (i) hardware, including digital color label printers and specialty OEM printing systems, portable data acquisition systems and airborne printers and networking systems used in the flight deck and cabin of military, commercial and business aircraft, (ii) related supplies required in the operation of the hardware, (iii) repairs and maintenance of hardware and (iv) service agreements.

Revenues disaggregated by primary geographic markets and major product types are as follows:

Primary geographical markets:

   Three Months Ended 
(In thousands)  May 2,
2020
   May 4,
2019
 

United States

  $ 19,789   $ 21,992 

Europe

   7,450    7,875 

Canada

   1,428    1,516 

Asia

   1,009    3,450 

Central and South America

   954    888 

Other

   289    460 
  

 

 

   

 

 

 

Total Revenue

  $30,919   $36,181 
  

 

 

   

 

 

 

   
Three Months Ended
 
(In thousands)  
May 1,
2021
   
May 2,
2020
 
United States
  $
 
 16,693   $
 
 19,789
 
Europe
   8,599    7,450 
Canada
   1,546    1,428 
Asia
   1,085    1,009 
Central and South America
   760    954 
Other
   395    289 
Total Revenue
  $29,078   $30,919 
Major product types:

   Three Months Ended 
(In thousands)  May 2,
2020
   May 4,
2019
 

Hardware

  $8,914   $ 12,918 

Supplies

   19,118    19,727 

Service and Other

   2,887    3,536 
  

 

 

   

 

 

 

Total Revenue

  $ 30,919   $36,181 
  

 

 

   

 

 

 

   
Three Months Ended
 
(In thousands)  
May 1,
2021
   
May 2,
2020
 
Hardware
  $7,647   $8,914 
Supplies
   18,211    19,118 
Service and Other
   3,220    2,887 
Total Revenue
  $29,078   $30,919 
9

Contract Assets and Liabilities

We normally do not have contract assets, which are primarily unbilled accounts receivable that are conditional on something other than the passage of time.
Our contract liabilities, which represent billings in excess of revenue recognized, are related to advanced billings for purchased service agreements and extended warranties. Contract liabilities were $375,000$330,000 and $466,000$285,000 at May 2, 20201, 2021 and January 31, 2020,2021, respectively, and are recorded as deferred revenue in the accompanying condensed consolidated balance sheet. We recognized $225,000 ofThe increase in the deferred revenue balance during the three-month periodthree months ended May 2, 2020, related1, 2021
is primarily due to cash payments received in advance of satisfying performance obligations in the current period, offset by $
127,000
of
revenue recognized during the period that was included in the deferred revenue balance at January 31, 2020.

2021. 

Contract Costs

We recognize an asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that certain costs related to obtaining sales contracts for our aerospace printer products meet the requirement to be capitalized. These costs are deferred and amortized based on the forecasted number of units sold over the remaining benefit term, which we currently estimate to be approximately 65 years. The balance of these contract assets at January 31, 20202021 was $944,000.$917,000. We amortized $15,000$9,000 of direct costs for the three months ended May 2, 20201, 2021 and the balance of deferred incremental direct costs net of accumulated amortization at May 2, 20201, 2021 was $929,000,$908,000, of which $59,000$74,000 is reported in other current assets and $870,000$834,000 is
reported in other assets in the accompanying condensed consolidated balance sheet.

Note 4 – Net Income Per Common Share

Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of shares and, if dilutive, common equivalent shares, determined using the treasury stock method for stock options, restricted stock awards and restricted stock units outstanding during the period.
A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:

   Three Months Ended 
   May 2,
2020
   May 4,
2019
 

Weighted Average Common Shares Outstanding – Basic

   7,073,278    6,970,914 

Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units

   31,365    277,412 
  

 

 

   

 

 

 

Weighted Average Common Shares Outstanding – Diluted

   7,104,643    7,248,326 
  

 

 

   

 

 

 

   
Three Months Ended
 
   
May 1,
2021
   
May 2,
2020
 
           
Weighted Average Common Shares Outstanding – Basic
   7,144,697    7,073,278 
Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units
   120,632    31,365 
Weighted Average Common Shares Outstanding – Diluted
   7,265,329    7,104,643 
For the three months ended May 2, 20201, 2021 and May 4, 2019,2, 2020, the diluted per share amounts do not reflect common equivalent shares outstanding of 865,157622,020 and 260,422,865,157,
respectively, because of their effect would have been anti-dilutive.

anti-dilutive effect.
10

Note 5 – Intangible Assets

Intangible assets are as follows:

   May 2, 2020   January 31, 2020 
(In thousands)  Gross
Carrying
Amount
   Accumulated
Amortization
  Currency
Translation
Adjustment
   Net
Carrying
Amount
   Gross
Carrying
Amount
   Accumulated
Amortization
  Currency
Translation
Adjustment
   Net
Carrying
Amount
 

Miltope:

              

Customer Contract Relationships

  $3,100   $ (2,098 $ —    $1,002   $3,100   $(2,021 $ —    $1,079 

RITEC:

              

Customer Contract Relationships

   2,830    (1,156  —      1,674    2,830    (1,076  —      1,754 

Non-Competition Agreement

   950    (918  —      32    950    (871  —      79 

TrojanLabel:

              

Existing Technology

   2,327    (1,136  68    1,259    2,327    (1,053  78    1,352 

Distributor Relations

   937    (320  22    639    937    (297  27    667 

Honeywell:

              

Customer Contract Relationships

   27,243    (7,521  —      19,722    27,243    (6,791  —      20,452 
  

 

 

   

 

 

  

 

 

   

 

 

   

 

 

   

 

 

  

 

 

   

 

 

 

Intangible Assets, net

  $ 37,387   $ (13,149 $ 90   $ 24,328   $ 37,387   $ (12,109 $ 105   $ 25,383 
  

 

 

   

 

 

  

 

 

   

 

 

   

 

 

   

 

 

  

 

 

   

 

 

 

   
May 1, 2021
   
January 31, 2021
 
(In thousands)
  
Gross

Carrying

Amount
   
Accumulated

Amortization
  
Currency

Translation

Adjustment
   
Net

Carrying

Amount
   
Gross

Carrying

Amount
   
Accumulated

Amortization
  
Currency

Translation

Adjustment
   
Net

Carrying

Amount
 
Miltope:
                                      
Customer Contract Relationships
  $3,100   $ (2,342 $ —     $758   $3,100   $ (2,284)  $ —     $816 
RITEC:
                                      
Customer Contract Relationships
   2,830    (1,507  —      1,323    2,830    (1,423  —      1,407 
TrojanLabel:
                                      
Existing Technology
   2,327    (1,497  186    1,016    2,327    (1,405  196    1,118 
Distributor Relations
   937    (422  84    599    937    (396  89    630 
Honeywell:
                                      
Customer Contract Relationships
   27,243    (10,443  —      16,800    27,243    (9,712  —      17,531 
                                       
Intangible Assets, net
  $
 
 
 
36,437
   $
 
 (16,211
 $ 270   $ 20,496   $ 34,437   $ (15,220 $ 285   $
 
 21,502 
                                       
There were no
0 impairments to intangible assets during the periods ended May 2, 20201, 2021 and May 4, 2019. 2, 2020.
With respect to the acquired intangibles included in the table above, amortization expense of $1.0 million and $1.1 
million has been included in the condensed consolidated statements of income for each of the three months ended May 2, 20201, 2021 and May 4, 2019, respectively.

2, 2020.

Estimated amortization expense for the next five fiscal years is as follows:

(In thousands)  Remaining
2021
   2022   2023   2024   2025 

Estimated amortization expense

  $ 3,018   $ 3,964   $ 3,957   $ 3,960   $ 3,392 

(In thousands)
  
Remaining
2022
   
2023
   
2024
   
2025
   
2026
 
Estimated amortization expense
  $2,968   $3,976   $4,075   $3,420   $3,026 
Note 6 – Inventories

Inventories are stated at the lower of cost(first-in,
(first-in,
first-out)
and net realizable value and include material, labor and manufacturing overhead. The components of inventories are as follows:

(In thousands)  May 2, 2020   January 31, 2020 

Materials and Supplies

  $ 20,793   $ 20,151 

Work-In-Process

   1,684    1,408 

Finished Goods

   16,781    17,992 
  

 

 

   

 

 

 
   39,258    39,551 

Inventory Reserve

   (6,701   (5,626
  

 

 

   

 

 

 
  $32,557   $33,925 
  

 

 

   

 

 

 

(In thousands)
  
May 1, 2021
   
January 31, 2021
 
Materials and Supplies
  $ 19,553   $ 20,265 
Work-In-Process
   1,989    2,076 
Finished Goods
   16,641    16,371 
           
    38,183    38,712 
Inventory Reserve
   (8,709   (8,652
           
   $29,474   $30,060 
           
11

Note 7 – Revolving Line of Credit

At May 2, 2020, Agreement and Debt

On March 24, 2021, we haveentered into a revolving line of credit underFirst Amendment to Credit Agreement (the “Amendment”) to our existing credit agreementAmended & Restated Credit Agreement (the “A&R Credit Agreement,” as amended by the Amendment; the “Amended Credit Agreement”) with Bank of America, N.A., as lender (the “Credit“Lender”), and our subsidiaries, ANI ApS and TrojanLabel. The A&R Credit Agreement, which we entered into on July, 30, 2020, amended and restated the Credit Agreement dated as of February 28, 2017 (the “Prior Credit Agreement”). Revolving by and among us, ANI ApS, TrojanLabel and the Lender. Immediately prior to the closing of the Amendment, we repaid
$
2.6
 million in principal amount of the term loan outstanding under the A&R Credit Agreement, resulting in an outstanding balance of the term loan of $
10.0
 million and
0
amount drawn and outstanding under the revolving credit facility under the A&R Credit Agreement.
The Amended Credit Agreement provides for (i) a term loan in the principal amount of $10.0 million, and (ii) a $22.5 million revolving credit facility available for general corporate purposes. At the closing of the Amendment, we borrowed the entire $10.0 million term loan which was used to refinance, in full, the outstanding term loan under the A&R Credit Agreement. Under the Amended Credit Agreement, revolving credit loans may continue to be borrowed, at our option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner. Amounts borrowed
The Amended Credit Agreement r
e
quires that the term loan be paid as follows: the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2021 through January 31, 2022 is $187,500; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2022 through January 31, 2023 is $250,000; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2023 through January 31, 2025 is $312,500; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2025 and July 31, 2025 is $500,000; and the entire remaining principal balance of the term loan is required to be paid on September 30, 2025. We may voluntarily prepay the term loan, in whole or in part, from time to time without premium or penalty (other than customary breakage costs, if applicable). We may repay borrowings under the revolving credit facility at any time without premium or penalty (other than customary breakage costs, if applicable), but in any event no later than September 30, 2025, at which time any outstanding revolving loans will be due and payable in full, and the revolving credit facility will terminate. We may reduce or terminate the revolving line of credit at any time, subject to certain
thresholds and conditions, without premium or penalty. 
The Amended Credit Agreement includes an uncommitted accordion provision under which the term loan and/or revolving credit facility commitments may be increased in an aggregate principal amount not exceeding $10.0 million, subject to obtaining the agreement of the Lender and the satisfaction of certain other conditions.
The interest rates under the A&R Credit Agreement were modified in the Amended Credit Agreement as follows: the term loan and revolving credit loans bear interest at a rate per annum equal to, at our option, either (a) the LIBOR rateRate as defined in the Amended Credit Agreement (or in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.0%1.60% to 1.5%2.30% based on our consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal funds’fund rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate, or (iii) the LIBOR rateRate plus 1.00% or (iv) 0.50%, plus a margin that varies within a range of 0.0%0.60% to 0.5%1.30% based on our consolidated leverage ratio.

At May 2, 2020, $11.5 million was drawn on the revolving line of credit. The outstanding balance bears interest at a weighted average annual rate of 2.52% In addition to certain other fees and $73,000 and $19,000 of interest has been incurred on this obligation and included in other expense in the accompanying condensed consolidated income statement for the three-month periods ended May 2, 2020 and May 4, 2019, respectively. At May 2, 2020, there was $6.0 million available for borrowing under the revolving credit facility. Pursuantexpenses that we are required to pay to the terms of the Fourth Amendment to our Credit Agreement, whichLender, we and Bank of America entered into in December 2019, the aggregate amount available for borrowings under the revolving line of credit will decrease to $10.0 million at the end of the third quarter of fiscal year 2021.

We are required to pay a commitment fee on the undrawn portion of the revolving credit facility atthat varies within a range of 0.15% and 0.30%

based on our
consolidated leverage ratio.
As under the rateA&R Credit Agreement, the loans under the Amended Credit Agreement are subject to certain mandatory prepayments, subject to various exceptions, from (a) net cash proceeds from certain dispositions of 0.25% per annum.

See Note 17–Subsequent Events–Letter Agreementproperty, (b) net cash proceeds from certain issuances of equity, (c) net cash proceeds from certain issuances of additional debt and (d) net cash proceeds from certain extraordinary receipts.

Amounts repaid under the revolving credit facility may be reborrowed, subject to continued compliance with Bank of America for a discussionthe Amended Credit Agreement. No amount of the letter agreement we entered

intoterm loan that is repaid may be reborrowed.

We must comply with Bankvarious customary financial and
non-financial
covenants under the Amended Credit Agreement. The financial covenants under the Amended Credit Agreement consist of Americaa maximum consolidated leverage ratio and a minimum consolidated fixed charge coverage ratio. The primary
non-financial
covenants limit our and our subsidiaries’ ability to incur future indebtedness, to place liens on June 22, 2020,assets, to pay dividends or distributions on their capital stock, to repurchase or acquire their capital stock, to conduct mergers or acquisitions, to sell assets, to alter their capital structure, to make investments and loans, to change the nature of their business, and to prepay subordinated indebtedness, in each case subject to certain exceptions and thresholds as set forth in the Amended Credit Agreement, certain of which provisions were modified by the Amendment.
The Lender is entitled to accelerate repayment of the loans and to terminate its revolving credit commitment under the Amended Credit Agreement upon the occurrence of any of various customary events of default, which include, among other things, suspendsevents, the following (which are subject, in some cases, to certain grace periods): failure to pay when due any principal, interest or other amounts in respect of the loans, breach of any of our access to the revolving line of creditcovenants or representations under the loan documents, default under any other of our or our subsidiaries’ significant indebtedness agreements, a bankruptcy, insolvency or similar event with respect to us or any of our subsidiaries, a significant unsatisfied judgment against us or any of our subsidiaries, or a change of control.
12

Our obligations under the Amended Credit Agreement continue to be secured by substantially all of our personal property assets (including a pledge of the equity interests held in ANI ApS, in our wholly-owned German subsidiary AstroNova GmbH, and in our wholly-owned French subsidiary AstroNova SAS), subject to certain exceptions, and by a mortgage on the terms described therein.

Note 8 –our owned real property in West Warwick, Rhode Island.

Long-Term Debt

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:

(In thousands)  May 2, 2020   January 31, 2020 

USD Term Loan (2.24% as of May 2, 2020 and 3.03% as of January 31, 2020); maturity date of November 30, 2022

  $8,250   $8,250 

USD Term Loan (2.24% as of May 2, 2020 and 3.03% as of January 31, 2020); maturity date of January 31, 2022

   4,784    4,784 
  

 

 

   

 

 

 
  $ 13,034   $ 13,034 

Debt Issuance Costs, net of accumulated amortization

   (98   (111

Current Portion of Term Loans

   (6,602   (5,208
  

 

 

   

 

 

 

Long-Term Debt

  $6,334   $7,715 
  

 

 

   

 

 

 

(In thousands)
  
May 1, 2021
   
January 31, 2021
 
USD Term Loan (2.60% as of May 1, 2021); maturity date of September 30, 2025
  $ 9,813   $—   
USD Term Loan (4.65% as of January 31, 2021) maturity date of June 15, 2022
   —      12,576 
           
   $9,813   $ 12,576 
Debt Issuance Costs, net of accumulated amortization
   (116   (141
Current Portion of Term Loans
   (813   (5,326
           
Long-Term Debt
  $8,884   $7,109 
           
During the three months ended May 1, 2021 and May 2, 2020, we recognized $115,000 and $79,000 of interest expense, respectively, which was included in other income (expense) in the accompanying condensed consolidated income statement.
The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of May 2, 20201, 2021 is as follows:

(In thousands)

Fiscal 2021, remainder

$ 5,208

Fiscal 2022

5,576

Fiscal 2023

2,250

$ 13,034

(In thousands)
    
Fiscal 2022, remainder
  $563 
Fiscal 2023
   1,000 
Fiscal 2024
   1,000 
Fiscal 2025
   1,250 
Fiscal 2026
   6,000 
      
   $9,813 
      
Note 8 – Paycheck Protection Program Loan 
On May 6, 2020, we entered into a loan agreement with, and executed a promissory note in favor of Greenwood Credit Union (“Greenwood”) pursuant to which we borrowed $4.4 million (the “PPP Loan”) from Greenwood pursuant to the Paycheck Protection Program (“PPP”) administered by the United States Small Business Administration (the “SBA”) and authorized by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), enacted on March 27, 2020. The terms of the PPP Loan were subsequently revised in accordance with the provisions of the Paycheck Protection Flexibility Act of 2020 (the “PPP Flexibility Act”) which was enacted on June 5, 2020.
The PPP Loan, which will mature on May 6, 2022, is unsecured and bears interest at a rate of 1.0% per annum, accruing from the loan date, and is payable monthly. NaN
payments are due on the PPP Loan until the date on which the SBA determines the amount of the PPP Loan that is eligible for forgiveness, so long as we apply for forgiveness within the ten months from the end of the twenty-four week period following the date of loan disbursement, but interest will continue to accrue during the deferral period. We have accrued interest for the PPP Loan in the amount of
$11,000, which is included in other expense in the accompanying condensed consolidated statements of income for the three month period ended May 1, 2021. A total of $44,000
of interest has been accrued on the PPP Loan and is included in other liabilities and accrued expenses in the accompanying condensed consolidated balance sheet as of May 1, 2021.
13

The PPP Loan may be prepaid at any time without penalty. The loan agreement and promissory note include customary provisions for a loan of this type, including prohibitions on our payment of dividends or repurchase of shares of our stock while the PPP Loan remains outstanding. The loan agreement and promissory note also include events of default relating to, among other things, payment defaults, breaches of the provisions of the loan agreement or the promissory note, and cross-defaults on other loans.
Subject to the limitations and conditions set forth in the CARES Act, the PPP Flexibility Act, and the regulations and guidance provided by the SBA with respect to the PPP, a portion of the PPP Loan may be forgiven in an amount up to the amount of the PPP Loan proceeds that we spent on payroll, rent, utilities and interest on certain debt during the twenty-four-week period following incurrence of the PPP Loan. Interest accrued on the forgiven portion of the principal amount of the PPP Loan is also forgiven. The amount of the PPP Loan to be forgiven in respect of rent, utilities and interest on certain debt will be capped at 40%
of the forgiven amount, with the remaining forgiven amount allocated to payroll costs. We have fully utilized the PPP Loan proceeds for qualifying expenses during fiscal year 2021 and in the first quarter of this current year we have applied for forgiveness of the PPP Loan (including all associated accrued interest) in accordance with the terms of the CARES Act, as amended by the PPP Flexibility Act. Whether our application for forgiveness will be granted and in what amount is subject to approval by the SBA and may also be subject to further requirements in any regulations and guidelines the SBA may adopt. The PPP Loan is classified as long-term debt in the condensed consolidated balance sheet until the
forgiveness determination has been made by the SBA. 

Note 9 – Derivative Financial Instruments and Risk Management

We

In 2017, we entered into a cross-currency interest rate swap to manage the interest rate risk and foreign currency exchange risk associated with the floating-rate foreign currency-denominated term loan borrowing by our Danish Subsidiary and an interest rate swap to manage the interest rate risk associated with our variable rate term loan borrowing. Both swaps have beenwere designated as cash flow hedges of floating-rate borrowings.

Our cross-currency interest rate swap agreement effectively modifiesmodified our exposure to interest rate risk and foreign currency exchange rate risk by converting our floating-rate debt denominated in U.S. Dollars on our Danish subsidiary’s books to a fixed-rate debt denominated in Danish Kroner for the term of the loan, thus reducing the impact of interest-rate and foreign currency exchange rate changes on future interest expense and principal repayments. This swap involvesinvolved the receipt of floating rate amounts in U.S. Dollars in exchange for fixed-rate interest payments in Danish Kroner, as well as exchanges of principal at the inception spot rate, over the life of the term loan.

The interest rate swap agreement we utilize on our term loan effectively modifieseff
e
ctively modified our exposure to interest rate risk by effectively converting our floating-rate term-loan debt to fixed-rate debt, for the next five years, thus reducing the impact of interest-rate changes on future interest expense. This swap involvesinvolved the receipt of floating rate amounts in U.S. Dollars in exchange for fixed rate payments in U.S. dollars over the life of the term loan.

As a direct result of the terms of the Lender’s conditions for entry into the A&R Credit Agreement, on July 30, 2020, we terminated these two swaps. The following table summarizesterms of the notional amount and fair valueA&R Credit Agreement caused those swaps to cease to be effective hedges of our derivative instruments:

   May 2, 2020   January 31, 2020 
Cash Flow Hedges      Fair Value Derivatives       Fair Value Derivatives 

(In thousands)

  Notional Amount   Asset   Liability   Notional Amount   Asset   Liability 

Cross-currency Interest Rate Swap

  $ 4,489   $ —    $ 192   $ 4,489   $ —    $ 250 

Interest Rate Swap

  $8,250   $ —    $202   $8,250   $—     $96

the underlying exposures. 

The fair valuetermination of both the Cross-currency Interest Rate Swap andswaps was contracted immediately prior to the Interest Rateend of the second quarter of fiscal 2021 at a cash cost of approximately
$
0.7
 million which was settled in the third quarter of fiscal 2021. Upon termination, the remaining balance of $
58,000
in accumulated other comprehensive loss related to the cross-currency interest rate swap are includedwas reclassified into earnings as the forecasted foreign currency interest payments will not occur. The remaining balance in accumulated other long-term liabilities oncomprehensive loss related to the condensed consolidated balance sheets forinterest rate swap of $ 
0.2
 million is being amortized into earnings through the periods ended May 2, 2020 and January 31, 2020.

original term of the hedge relationship as the underlying floating interest rate debt still exists.

The following table presents the impact of our derivative instruments in our condensed consolidated financial statements for the three months ended May 2, 20201, 2021 and May 4, 2019:

   Amount of Gain (Loss)
Recognized in OCI
on Derivative
   Location of
Gain (Loss)
Reclassified
from Accumulated
OCI into
Income (Expense)
  Amount of Gain (Loss)
Reclassified from
Accumulated OCI
into Income (Expense)
 

Cash Flow Hedge

(In thousands)

  May 2,
2020
  May 4,
2019
  May 2,
2020
   May 4,
2019
 

Swap Contracts

  $ (58 $ 149    Other Income (Expense $ 43   $ 185 
  

 

 

  

 

 

    

 

 

   

 

 

 

2, 2020:

   
Three Months Ended
 
   
Amount of Gain (Loss)

Recognized in OCI

on Derivative
  
Location of

Gain (Loss)

Reclassified

from Accumulated

OCI into

Income
   
Amount of Gain (Loss)

Reclassified from

Accumulated OCI

into Income
 
Cash Flow Hedge
(In thousands)
  
May 1,

2021
   
May 2,

2020
   
May 1,

2021
  
May 2,

2020
 
Swap contracts  $—     $ (58  Other Expense   $ (20) $ 43 
                        
At May 2, 2020,1, 2021, we expect to reclassify approximately $30 thousand$0.1 million of net gainslosses on the frozen OCI balance associated with the terminated interest rate swap contracts from accumulated other comprehensive loss to earnings during the next 12 months due to changes in foreign exchange rates and the payment of variable interest associated with the floating-ratefloating interest rate debt.

14

Note 10 – Royalty Obligation

In fiscal 2018, we entered into an Asset Purchase and License Agreement (the “Honeywell Agreement”) with Honeywell International, Inc. (“Honeywell”) to acquire an exclusive, perpetual, world-wide license to manufacture Honeywell’s narrow-format flight deck printers for two aircraft families along with certain inventory used in the manufacturing of the licensed printers. The purchase price included a guaranteed minimum royalty payment of $15.0 million, to be paid over ten years. Royalty payments areyears, based on gross revenues from the sales of the printers, paper and repair services of the licensed products. The royalty rates vary based on the year in which they are paid or earned, and product sold or service provided, and range from single-digit to mid double-digit percentages of gross revenue.

The guaranteed minimum royalty payment obligation was recorded at the present value of the minimum annual royalty payments using a present value factor of 2.8%, which is based on the estimated
after-tax
cost of debt for similar companies. As of May 2, 2020,1, 2021, we had paid an aggregate of $4.0$6.0 million of the guaranteed minimum royalty obligation. At May 2, 2020,May1, 2021, the current portion of the outstanding guaranteed minimum royalty obligation of $2.0 million is to be paid over the next twelve months and is reported as a current liability and the remainder of $7.5$5.7 million is reported as a long-term liability on our condensed consolidated balance sheet. In addition to the guaranteed minimum royalty payments, we also incur excess royalty expense in connection with the Honeywell Agreement. We did not0t incur any excess royalty expense for the three-monththree month period ended May 2, 2020. We did incur $0.6 1, 2021. A total of $0.2 
million in excess royalties was paid in the first quarter of the current fiscal year and there are no excess royalty expensepayables due as a result of this agreement for the three-month period ended May 4, 2019, which is included in cost of revenue in our condensed consolidated statements of income for that period. A total of $0.6 million of excess royalty is payable and reported as a current liability on our condensed consolidated balance sheet at May 2, 2020.

1, 2021.

Note 11 – Leases

We enter into lease contracts for certain of our facilities at various locations worldwide. Our leases have remaining lease terms of 1 to 86 years, some of which include options to extend the lease term for periods of up to five years when it is reasonably certain that we will exercise such options.

Balance sheet and other information related to our leases is as follows:

Operating Leases

(In thousands)

  Balance Sheet Classification  May 2,
2020
   January 31,
2020
 

Lease Assets

  Right of Use Assets  $1,553   $1,661 

Lease Liabilities – Current

  Other Accrued Expenses   391    416 

Lease Liabilities – Long Term

  Lease Liabilities   1,199    1,279 

Operating Leases
(In thousands)
  
Balance Sheet Classification
   
May 1,

2021
   
January 31,

2021
 
Lease Assets
   Right of Use Assets   $1,302   $ 1,389 
Lease Liabilities – Current
   Other Liabilities and Accrued Expenses    366    372 
Lease Liabilities – Long Term
   Lease Liabilities    983    1,065 
Lease cost information is as follows:

                              
      Three Months Ended 

Operating Leases

(In thousands)

  

Statement of Income Classification

  May 2,
2020
   May 4,
2019
 

Operating Lease Costs

  General and Administrative Expense  $120   $92 


      
Three Months Ended
 
Operating Leases
(In thousands)
  
Statement of Income Classification
  
May 1,
2021
   
May 2,
2020
 
Operating Lease Costs  General and Administrative Expense  $136   $120 
Maturities of operating lease liabilities are as follows:

(In thousands)

  May 2,
2020
 

2021

  $305 

2022

   348 

2023

   298 

2024

   272 

2025

   168 

Thereafter

   391 
  

 

 

 

Total Lease Payments

   1,782 

Less: Imputed Interest

   (192
  

 

 

 

Total Lease Liabilities

  $ 1,590 
  

 

 

 

(In thousands)
  
May 1,

2021
 
2022, remaining
  $279 
2023
   317 
2024
   290 
2025
   182 
2026
   162 
Thereafter
   267 
      
Total Lease Payments
   1,497 
Less: Imputed Interest
   (148
      
Total Lease Liabilities
  $1,349 
      
As of May 2, 2020,1, 2021, the weighted-average remaining lease term and weighted-average discount rate for our operating leases are 5.65.0 years and 3.99%4.0%, respectively. We calculated the weighted-average discount rate using incremental borrowing rates, which equal the rates of interest that we would pay to borrow funds on a fully collateralized basis over a similar term.

15

Supplemental cash flow information related to leases is as follows:

                    
   Three Months Ended 

(In thousands)

  May 2,
2020
   May 4,
2019
 

Cash paid for amounts included in the measurement of lease liabilities:

  $106 �� $100 
   
Three Months Ended
 
(In thousands)
  
May 1,
2021
   
May 2,
2020
 
Cash paid for amounts included in the measurement of lease liabilities:          
Operating cash flows for operating
leases
  $92   $106 

Note 12 – Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss (“AOCL”) by component are as follows:

(In thousands)

  Foreign Currency
Translation
Adjustments
   Cash
Flow
Hedges
   Total 

Balance at January 31, 2020

  $(985  $ (108  $ (1,093

Other Comprehensive Loss before reclassification

   (142   (46   (188

Amounts reclassified from AOCL to Earnings

   —      (33   (33
  

 

 

   

 

 

   

 

 

 

Other Comprehensive Loss

   (142   (79   (221
  

 

 

   

 

 

   

 

 

 

Balance at May 2, 2020

  $ (1,127  $ (187  $ (1,314
  

 

 

   

 

 

   

 

 

 

(In thousands)
  
Foreign Currency

Translation

Adjustments
   
Cash

Flow

Hedges
   
Total
 
Balance at January 31, 2021
  $ (275  $ (109  $ (384
Other Comprehensive Loss before reclassification
   (81   —      (81
Amounts reclassified from AOCL to Earnings
   —      16    16 
                
Other Comprehensive Income (Loss)
   (81   16    (65
                
Balance at May 1, 2021
  $ (356)   $(93  $(449
                
The amounts presented above in other comprehensive loss are net of taxes except for translation adjustments associated with our German and Danish subsidiaries.

Note 13 – Share-Based Compensation

We have one equity incentive plan from which we are authorized to grant equity awards, the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards, including incentive stock options,non-qualified stock options, stock appreciation rights, time-based restricted stock units (“RSUs”), or performance-based restricted stock units (“PSUs”) and restricted stock awards (RSAs)(“RSAs”). The 2018 Plan authorizes
a
uthorizes the issuance of up to
 950,000 shares of common stock, plus an additional number of shares equal to the number of shares subject to awards granted under previous equity incentive plans that are forfeited, cancelled, satisfied without the issuance of stock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to any unvested award, that are reacquired by us at not more than the grantee’s purchase price (other than by exercise). Under the 2018 Plan, all awards to employees generally have a minimum vesting period of one year. Options granted under the 2018 Plan must be issued at an exercise price of not less than the fair market value of our common stock on the date of grant and expire after ten years. Under the 2018
Plan, 293,014 of there were 
145,534
unvested shares of restricted stockRSUs; 75,926 unvested PSUs; 48,000 unvested RSAs and options to purchase an aggregate of
 135,500
shares were outstanding as of May 2, 2020.

1, 2021. 

In addition to the 2018 Plan, we previously granted equity awards under our 2015 Equity Incentive Plan (the “2015 Plan”) and our 2007 Equity Incentive Plan (the “2007 Plan”). No new awards may be issued under either the 2007 or 2015 plans, but outstanding awards will continue to be governed by those plans. As of May 2, 2020,1, 2021, options to purchase an aggregate of 344,245327,418 shares were outstanding under the 2007 Plan and 15,113 3,750
unvested shares of restricted stockRSUs and options to purchase an aggregate of 148,725
141,375
shares
were outstanding under the 2015 Plan.

We also have a
Non-Employee
Director Annual Compensation Program (the “Program”), under which each of our
non-employee
directors automatically receives a grant of restricted stock on the date of their
re-election
to our board of directors. The number of whole shares granted is equal to the number calculated by dividing the stock component of the director compensation amount determined by the compensation committee for that year by the fair market value of our stock on that day. The value of the restricted stock award for fiscal 20212022 is $60,000. Shares of restricted stock granted under the Program become vested on the first anniversary of the date of grant, conditioned upon the recipient’s continued service on our board of directors through that date.

16

Share-based compensation expense was recognized as follows:

   Three Months Ended 
(In thousands)  May 2,
2020
   May 4,
2019
 

Stock Options

  $133   $212 

Restricted Stock Awards and Restricted Stock Units

   357    384 

Employee Stock Purchase Plan

   5    5 
  

 

 

   

 

 

 

Total

  $495   $601 
  

 

 

   

 

 

 

   
Three Months Ended
 
(In thousands)
  
May 1,
2021
   
May 2,
2020
 
Stock Options
  $ 105   $ 133 
Restricted Stock Awards and Restricted Stock Units
   370    357 
Employee Stock Purchase Plan
   3    5 
Total
  $478   $495 
Stock Options

There were no0 stock options granted during the three-month periodsthree months ended May 2, 20201, 2021 and May 4, 2019.

2, 2020.

Aggregated information regarding stock option activity for the three months ended May 2, 20201, 2021 is summarized below:

   Number of
Options
   Weighted Average
Exercise Price
 

Outstanding at January 31, 2020

   679,044   $14.46 

Granted

   —      —   

Exercised

   (800   7.36 

Forfeited

   (48,374   12.83 

Canceled

   (1,400   7.36 
  

 

 

   

 

 

 

Outstanding at May 2, 2020

   628,470   $14.61 
  

 

 

   

 

 

 

   
Number of
Options
   
Weighted Average
Exercise Price
 
Outstanding at January 31, 2021
   622,083   $ 14.63 
Granted
   0      0   
Exercised
   (3,775   8.84 
Forfeited
   (14,015   14.96 
Canceled
   0      0   
           
Outstanding at May 1, 2021
   604,293   $14.66 
           
Set forth below is a summary of options outstanding at May 2, 2020:

   Outstanding   Exercisable 

Range of

Exercise prices

  Number
of
Shares
   Weighted-
Average
Exercise
Price
   Weighted-
Average
Remaining
Contractual Life
   Number
of
Shares
   Weighted-
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
 

$5.00-10.00

   42,281   $7.98    2.0    42,281   $7.98    2.0 

$10.01-15.00

   364,464   $13.63    5.5    319,166   $13.65    5.3 

$15.01-20.00

   221,725   $17.48    7.5    128,871   $16.92    7.1 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   628,470   $14.61    6.0    490,318   $14.02    5.5 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

1, 2021:

Outstanding
   
Exercisable
 
Range of
Exercise prices
  
Number
of
Shares
   
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual Life
   
Number
of
Shares
   
Weighted-
Average
Exercise
Price
   
Weighted
Average
Remaining
Contractual
Life
 
$5.00-10.00
   37,244   $7.97    1.2    37,244   $7.97    1.2 
$10.01-15.00
   349,299   $ 13.62    4.6    337,299   $ 13.61    4.5 
$15.01-20.00
   217,750   $17.47    6.6    165,492   $17.21    6.4 
                               
    604,293   $14.66    5.1    540,035   $14.32    4.9 
                               
As of May 2, 2020,1, 2021, there was approximately $0.6$0.1 million of unrecognized compensation expense related to stock options which is expected to be recognized over a weighted average period of approximately 1.30.7 years.

Restricted Stock Units Performance Based Restricted Stock Units(RSUs) and Restricted Stock Awards

(RSAs)

Aggregated information regarding RSU PSU and RSA activity for the three months ended May 2, 20201, 2021 is summarized below:

   RSUs, PSUs &
RSAs
   Weighted Average
Grant Date Fair Value
 

Outstanding at January 31, 2020

   134,634   $16.79 

Granted

   197,131    7.94 

Vested

   (23,638   13.00 
  

 

 

   

 

 

 

Outstanding at May 2, 2020

   308,127   $11.42 
  

 

 

   

 

 

 

   
RSAs & RSUs
   
Weighted Average
Grant Date Fair Value
 
Outstanding at January 31, 2020
   197,413   $9.96 
Granted
   124,096    14.26 
Vested
   (48,299   10.26 
Forfeited
   0      0   
           
Outstanding at May 1, 2021
   273,210   $ 11.86 
           
As of May 2, 2020,1, 2021, there was approximately $2.7$2.5 million of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of 1.1 years.

17

Employee Stock Purchase Plan

We have an Employee Stock Purchase Plan allowing eligible employees to purchase shares of common stock at a 15% discount from fair value on the first or last day of an offering period, whichever is less. A total of 247,500 shares were reserved for issuance under this plan. During the three months ended May 1, 2021 and May 2, 2020, and May 4, 2019, there were 1,813 and 3,755 and 1,571 shares, respectively,r
e
spectively, purchased under this plan.
As of May 2, 2020, 21,219 1, 2021, 
8,561
shares remain available for purchase under our Employee Stock Purchase Plan.

Note 14 – Income Taxes

Our effective tax rates for the period are as follows:

   Three Months
First Quarter
Ended
 

Fiscal 2022
(62.0)% 
Fiscal 2021

   (37.6)% 

Fiscal 2020

19.0

We determine our estimated annual effective tax rate at the end of each interim period based on full-year forecasted
pre-tax
income and facts known at that time. The estimated annual effective tax rate is applied to the
year-to-date
pre-tax
income at the end of each interim period with the cumulative effect of any changes in the estimated annual effective tax rate being recorded in the fiscal quarter in which the change is determined. The tax effect of significant unusual items is reflected in the period in which they occur.

During the three months ended May 1, 2021, we recognized an income tax benefit of approximately $227,000. The effective tax rate in this period was directly impacted by a $276,000 tax benefit related to the expiration of the statute of limitations on a previously uncertain tax position and a $37,000 tax benefit arising from windfall tax benefits related to the Company’s stock. During the three months ended May 2, 2020, we recognized an income tax benefit of approximately $118,000. The effective tax rate in this period was directly impacted by a reduction in our forecasted operating results for fiscal 2021 and a $78,000 tax benefit related to the expirationreversal of the statute of limitations on previously uncertain tax positions. During the three months ended May 4, 2019, we recognized an income tax expense of approximately $400,000. The effective tax rate in this period was directly impacted by a $53,000 tax benefit relatedpositions due to the expirationfinalization of the statute of limitations on a previously uncertain tax position and a $97,000 windfall tax benefit related to our stock.

We maintain a valuation allowance on some of our deferred tax assets in certain jurisdictions. A valuation allowance is required when, based upon an assessment of various factors, including recent operating loss history, anticipated future earnings, and prudent and reasonable tax planning strategies, it is more likely than not that some portion of the deferred tax assets will not be realized.

IRS audit.

Unrecognized tax benefits represent the difference between tax positions taken or expected to be taken in a tax return and the benefits recognized for financial reporting purposes. As of May 2, 2020,1, 2021, our cumulative unrecognized tax benefits totaled $319,000$221,000 compared to $362,000$384,000 as of January 31, 2020.2021. Besides the expiration of the statute of limitations on a previously uncertain tax position, there were no 0
other developments affecting our unrecognized tax benefits during the quarter ended May 2, 2020.

1, 2021.

Note 15 – Segment Information

We report two segments: Product Identification (“PI”) and Test & Measurement (“T&M”). We evaluate segment performance based on the segment profit (loss) before corporate expenses.

18

Summarized below are the Revenue and Segment Operating Profit (Loss) for each reporting segment:

   Three Months Ended 
   Revenue   Segment Operating Profit (Loss) 

(In thousands)

  May 2,
2020
   May 4,
2019
   May 2,
2020
  May 4,
2019
 

PI

  $22,380   $23,591   $3,146  $2,886 

T&M

   8,539    12,590    (156  2,581 
  

 

 

   

 

 

   

 

 

  

 

 

 

Total

  $30,919   $36,181    2,990   5,467 
  

 

 

   

 

 

    

Corporate Expenses

       2,327   2,999 
      

 

 

  

 

 

 

Operating Income

       663   2,468 

Other Expense, Net

       (349  (368
      

 

 

  

 

 

 

Income Before Income Taxes

       314   2,100 

Income Tax (Benefit) Provision

       (118  400 
      

 

 

  

 

 

 

Net Income

      $432  $1,700 
      

 

 

  

 

 

 

   
Three Months Ended
 
   
Revenue
   
Segment Operating Profit
(Loss)
 
(In thousands)
  
May 1,
2021
   
May 2,
2020
   
May 1,
2021
  
May 2,
2020
 
Product Identification
  $23,098   $22,380   $2,729  $3,146 
T&M
   5,980    8,539    350   (156
                    
Total
  $29,078   $30,919    3,079   2,990 
                    
Corporate Expenses
        2,344   2,327 
��              
Operating Income
        735   663 
Other Expense, Net
        369   349 
               
Income Before Income Taxes
        366   314 
Income Tax Benefit
        (227  (118
               
Net Income
       $593  $432 
               
Note 16 – Fair Value

Assets and Liabilities Recorded at Fair Value on a Recurring Basis

The following tables provide a summary of the financial liabilities that are measured at fair value as of May 2, 2020 and January 31, 2020:

Liabilities measured at fair value:

  Fair value measurement at
May 2, 2020
   Fair value measurement at
January 31, 2020
 
(In thousands)  Level 1   Level 2   Level 3   Total   Level 1   Level 2   Level 3   Total 

Cross-Currency Interest Rate Swap Contract (included in Other Long-Term Liabilities)

  $—    $192   $—    $192   $—    $250   $—    $250 

Interest Rate Swap Contract (included in Other Long-Term Liabilities)

   —      202    —      202    —      96   —      96

Earnout Liability (included in Other Long-Term Liabilities)

   —      —      —      —      —      —      14    14 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Liabilities

  $—    $394   $—     $394   $—    $346   $14   $360 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

We use the market approach to measure fair value of our derivative instruments. Derivative instruments were measured at fair value using readily observable market inputs, such as quotations on interest rates and foreign exchange rates, and are classified as Level 2 because they areover-the-counter contracts with a bank counterparty that are not traded in an active market.

Assets and Liabilities Not Recorded at Fair Value

Our long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:

   May 2, 2020 
   Fair Value Measurement   Carrying
Value
 

(In thousands)

  Level 1   Level 2   Level 3   Total 

Long-Term Debt and related current maturities

  $—    $—    $13,227   $13,227   $13,034 
   January 31, 2020 
   Fair Value Measurement   Carrying
Value
 

(In thousands)

  Level 1   Level 2   Level 3   Total 

Long-Term Debt and related current maturities

  $—    $—    $13,258   $13,258   $13,034 

   
May 1, 2021
 
   
Fair Value Measurement
     
(In thousands)
  
Level 1
   
Level 2
   
Level 3
   
Total
    Carrying
Value 
 
Long-Term debt and related current maturities
  $ —     $ —     $ 9,821   $ 9,821   $9,813 
19

   
January 31, 2021
 
   
Fair Value Measurement
     
(In thousands)
  
Level 1
   
Level 2
   
Level 3
   
Total
    Carrying
Value 
 
Long-Term debt and related current maturities
  $ —   $ —   $12,586   $12,586   $12,576 
The above table does not include the PPP loan, as the fair value of the PPP loan approximates its carrying value.
The fair value of our long-term debt, including the current portion, is estimated by discounting the future cash flows using current interest rates at which similar loans with the same maturities would be made to borrowers with similar credit ratings and is classified as Level 3.

Note 17 – Subsequent Events

Payroll Protection Program Loan

On May 6, 2020, we entered into a loan agreement with, and executed a promissory note in favor of Greenwood Credit Union (“Greenwood”) pursuant to which we borrowed $4.4 million (the “ PPP Loan”) from Greenwood pursuant to the Paycheck Protection Program (“PPP”) administered by the United States Small Business Administration (the “SBA”) and authorized by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), enacted on March 27, 2020.

The terms of the PPP Loan were subsequently revised in accordance with the provisions of the Paycheck Protection Flexibility Act of 2020 (the “PPP Flexibility Act”) which was enacted on June 5, 2020.

The PPP Loan, which will mature on the fifth anniversary of the date on which we submit our request for forgiveness with respect to the PPP Loan, is unsecured and bears interest at a rate of 1.0% per annum. The PPP Loan may be prepaid at any time without penalty. The Loan Agreement and Promissory Note include customary provisions for a loan of this type, including prohibitions on our payment of dividends or repurchase of shares of our stock while the PPP Loan remains outstanding. The Loan Agreement and Promissory Note also include events of default relating to, among other things, payment defaults, breaches of the provisions of the Loan Agreement or the Promissory Note, and cross-defaults on other loans.

Subject to the limitations and conditions set forth in the CARES Act, the PPP Flexibility Act, and the regulations and guidance provided by the SBA with respect to the PPP, a portion of the PPP Loan in an amount up to the amount of the PPP Loan proceeds that we spend on payroll, rent, utilities and interest on certain debt during the twenty-four-week period following incurrence of the PPP Loan, may be forgiven under the PPP. The amount of the PPP Loan to be forgiven in respect of rent, utilities and interest on certain debt will be capped at 40% of the forgiven amount, with the remaining forgiven amount allocated to payroll costs. We intend to utilize the proceeds of the PPP Loan in a manner which will enable us to qualify for forgiveness of the PPP Loan. However, no assurance can be provided that all or any portion of the PPP Loan will be forgiven.

Letter Agreement with Bank of America

On June 22, 2020, we entered into a Letter Agreement with Bank of America, N.A. Pursuant to that agreement, Bank of

America agreed to waive compliance with certain financial covenants in our Credit Agreement related to our consolidated leverage ratio and consolidated EBITDA (as defined in the Credit Agreement) for the measurement period ending May 2, 2020. The Letter Agreement imposes an additional financial covenant that requires us to have, as of June 30, 2020, consolidated EBITDA of not less than $9.5 million on a trailing twelve-months basis, and to report our compliance with such covenant on or before August 15, 2020. The Letter Agreement provides that such covenant will not be tested until August 15, 2020 and we do not expect to be in compliance with the covenants at the time, hence constituting an immediate event of default under the Credit Agreement. However, we and Bank of America are actively negotiating the terms of an amendment to restructure the Credit Agreement that would provide for mutually acceptable revised financial and operational covenants and other mutually acceptable revised terms and we both fully expect that amendment to be executed prior to August 15, 2020. The effect of the Letter Agreement therefore is to give both parties sufficient time to complete the relevant documentation and also enable us to execute the amendment by that deadline.

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Business Overview

This section should be read in conjunction with our condensed consolidated financial statements included elsewhere herein and our Annual Report on Form
10-K
for the fiscal year ended January 31, 2020.

AstroNova is2021.

We are a multi-nationalmultinational enterprise that leverages itsour proprietary data visualization technologies to design, develop, manufacture, distribute and service a broad range of products that acquire, store, analyze and present data in multiple formats. We organize our structure around a core set of competencies, including research and development, manufacturing, service, marketing and distribution. We market and sell our products and services through the following two segments:

Product Identification (“PI”) – offers color and monochromatic digital label printers, over-printers
direct-to-package
printers and custom OEM printers. PI also offersprovides software to design, manage and print labeling and packaging images locally and across networked printing systems, as well as all related printing supplies such as pressure sensitive labels, tags, inks, toners and thermal transfer ribbons used by digital printers. PI also provides
on-site
and remote service, spare parts and various service contracts.

Test and Measurement (“T&M”) – offers a suite of products and services that acquire data from local and networked data streams and sensors as well as wired and wireless networks. The T&M segment includes a line of aerospace printers that are used to print hard copies of data required for the safe and efficient operation of aircraft including navigation maps, clearances, arrival and departure procedures, flight itineraries, weather maps, performance data, passenger data, and various air traffic control data. Aerospace products also include aircraft networking systems for high-speed onboard data transfer.

T&M also provides repairs, service and spare parts.

We market and sell our products and services globally through a diverse distribution structure of direct sales personnel, manufacturers’ representatives and authorized dealers that deliver a full complement of branded products and services to customers in our respective markets. Our growth strategy centers on organic growth through product innovation made possible by research and development initiatives, as well as strategic acquisitions that fit into or complement existing core businesses.

In fiscal 2018,

COVID-19
Update—Overview
Our business has been materially adversely affected by the global
COVID-19
pandemic. We operate in several regions of the world, with the largest concentration of team members in North America and Europe, and a small presence in Asia. Throughout the pandemic we, entered into an Asset Purchase and License Agreement (“Honeywell Agreement”)many other businesses and other organizations with Honeywell International, Inc. (“Honeywell”) pursuantwhich we do business directly or which otherwise impact us, have taken and are continuing to take steps to avoid or reduce infection as recommended by the public health authorities, including working remotely from home and limiting business travel . Although travel restrictions between regions have recently loosened to a limited degree, many restrictions still remain in place, especially in Europe, and it is too early to determine the precise impact that the recent relaxation of restrictions will have our business. Additionally, while vaccine availability and inoculation rates have had a favorable impact and, as a result, most public health authorities in the United States and Asia have determined that the quarantines, travel restrictions, business closures, cancellations of public gatherings and other measures that have been implemented as a result of the pandemic are no longer necessary, this is not uniformly accepted and we have not determined exactly how our own business practices and those of with whom we do business, will change as a result.
20

Since the
COVID-19
pandemic began, we have monitored government recommendations and regulations and made good faith efforts to comply with those regulations and the best practices recommendations issued by a variety of governmental health authorities and manufacturing industry organizations to which we acquiredbelong. We have also made significant modifications to our normal operations because of the exclusive perpetual
COVID-19
pandemic, including requiring most
non-production
related team members to work remotely, at least part-time. At this time, most of these measures will continue to remain in place for the near term, although we do plan to relax some of them in response to the recent governmental relaxation of restrictions, we do not know when, or if it will become practical to relax or eliminate some, or all of these measures altogether. Since the start of the pandemic, we have maintained most of manufacturing operational capacity at our facilities located in West Warwick, Rhode Island, as well as our manufacturing facilities in Canada and Germany. In the West Warwick and Canadian operations there were periods when a number of team members were unable to keep work schedules due to the effects of the pandemic, which resulted in reduced production capacity that led to longer order fulfillment lead times and as a result, reduced revenues. While those issues have largely abated, they are still impacting our operations in Germany. The extent to which the
COVID-19
pandemic continues to negatively impact our manufacturing production will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity
of COVID-19 associated
variants, the continued efficacy of vaccinations and the willingness of our employees and others to become vaccinated, among others. We expect that our operations and modalities of
on-site
and remote work will be impacted permanently, as will our increased safety protocols and the other adaptations undertaken during the pandemic, but we are still developing our plans and cannot predict the result yet.
During the
COVID-19
pandemic, we have experienced some difficulties in obtaining raw materials and components for our products. As the pandemic has begun to abate, some of the structural dislocations in the global economy that resulted are prolonging these difficulties. We have been able to recover from these difficulties, but we have had to incur some additional costs in expedited and express shipping fees. These difficulties have impacted our efficiency and our ability to satisfy customer requirements, but we do not believe that they have materially impacted our financial results or our relationships with our customers. We are currently monitoring the world-wide licensedelays in transit time, as freight carriers are now experiencing significant delays in overseas shipments. We are addressing these issues through long range planning and supplementing inventories as needed. We are also in particular monitoring the extended lead times on active electronic components and utilizing several strategies, including blanket orders, vendor-bonded inventories, extended commitments to manufacture Honeywell’s narrow formatour supply base, and seeking alternative suppliers. Additionally, we have taken actions to maintain regular contact with our important vendors and have increased our forecasting horizon for our products to help us better manage our supply chain. Our strategies to counteract the impact of the pandemic have tended to increase the amount of inventory we maintain, but because of the complexity of our supply chain, it is impossible to isolate the precise impact of each element. We will continue to monitor our supply chain going forward and update our mitigation strategies as we determine appropriate. While we are not able to predict what the full impact of the current supply chain difficulties even as the
COVID-19
pandemic starts to winds down, if we the steps we are taking are not effective, it could have a material adverse impact on our results of operations.
It is not possible at this time to estimate the how the continued development of the recovery from the
COVID-19
pandemic itself or the consequences of its aftermath will impact our business, customers, suppliers or other business partners, and the degree it will adversely change our operational capacity and the efficiency of our team members or affect our results of operations and financial condition.
21

Product Identification Update
The global
COVID-19
pandemic has also negatively impacted sales of our Product Identification hardware products primarily as a result of the impact of travel restrictions on our sales efforts, as most customers historically have preferred
in-person
demonstrations of these printers at their production sites prior to placing orders with us and those visits have been severely limited. Additionally, the widespread cancellation of trade shows, which traditionally provided an effective forum for customers to consider our products, has also had an adverse impact on traditional methods of sales lead generation. However, we believe we have been able to partially offset these negative impacts by placing a greater reliance on various forms of digital advertising and internet-based marketing techniques, including remote video demonstrations and support, which has proven effective in obtaining sales. Despite favorable market reception to our recently refreshed and expanded product lines, the degree to which we will be able to maintain or grow the level of hardware revenues through the changes we have made to our
go-to-market
strategies remains unclear. As the
COVID-19
pandemic abates, and it becomes possible for our direct sales force and distributors to travel to visit customers and attend and present products at trade shows (if they are even offered), it is likely that some reversion to those historical sales methods will occur, but some of the
COVID-19
induced adaptations are also likely to become permanent. At this time however, we do not know how that mix of sales strategies will evolve and how they will impact the results of operations for this segment.
Despite the pandemic, underlying overall demand remained strong through this period and in general, we believe that the diversified nature of our end markets and the relative concentration of business in consumer
non-durable
market related applications impart a greater degree of near- and longer-term stability to our Product Identification segment.
Test & Measurement Update
Our sales of flight deck printers for the Boeing 737 and Airbus 320 aircraft. This addedaircraft have been severely impacted by the chain of events that occurred after two highest volume commercial737 MAX aircraft programs in regular production to our product portfolio.

crashed. In March 2019, all major civil aviation authorities worldwide grounded the Boeing 737 MAX aircraft for safety reasons. In April 2019, Boeing reduced the number of 737 MAX aircraft produced per month from 52 to 42, and in January 2020, Boeing ceased production of the 737 MAX completely. Although, at this time it is not known when the Boeing 737 MAX will be certified to return to service by the various civil aviation authorities, onOn May 27, 2020, in anticipation of thisan eventual certification, Boeing announced that it would

re-start
production at low initial rates and gradually increase production in the future. Once
On August 3, 2020, the United States Federal Aviation Administration (the “FAA”) issued a notice of proposed rulemaking for a Boeing 737 MAX airworthiness directive, and on November 18, 2020 the FAA certified the model for return to service in the United States. On January 27, 2021, the European Union Aviation Safety Agency (EASA) approved the return to service of the Boeing 737 MAX in Europe. The exact timing of
re-certification
by other worldwide civil aviation authorities is unknown but we expect that most will permit a return to service later in 2021. Before any individual 737 MAX aircraft can return to commercial service, all civilian aviation authority agency certification requirements relevant to each carrier must be met. As these requirements vary, and can be quite extensive, the exact timing of the recertification and return to service of the 737 MAX fleet in each geographical area is unclear at this time and will depend on the ability of Boeing and each airline to complete the required steps.
Aircraft manufacturing rather than aircraft deliveries primarily drives demand for our airborne printer products. We have experienced very low levels of 737 MAX new printer orders and shipments since the production halt, as Boeing is now producing a small number of new aircraft per month. The majority of our future 737 MAX printer sales volume will be tied to the pace of Boeing’s manufacturing dates and delivery schedules, forand the pace of the recovery in their aircraft customers are established, we expectproduction rates is uncertain and will likely be prolonged. We believe that Boeing and Boeing’s customers will begin to orderhas already installed our printers from us for those aircraft. However, we expectin most of the airplanes that the adverse impact on our revenue and profitability by the production decline to date will continue until customer demand returnsit has completed and that the impact will abate as demand begins to grow again.

On March 11, 2020, the World Health Organization declaredCOVID-19, a respiratory illness caused by a novel coronavirus,require our printers to be apandemic. COVID-19 has spread throughoutinstalled prior to delivery. Though we have noted that some airlines are now ordering new 737 MAX aircraft again, and we have seen slight increases in orders for future delivery, the United States and the resteffect of the worldimproving outlook and has impacted all major marketsits timing remains unknown. The precipitous decline in which we, our customers, our suppliers and our other business partners conduct business. Governments in affected regions have, and we expect that they will continue to implement safety precautions including quarantines, travel restrictions, business closures, cancellations of public gatherings and any other measures as they deem necessary. Many organizations and individuals, including us and our employees are taking additional steps to avoid or reduce infection, including limiting travel and working from home when possible. These measures are disrupting normal business operations both inside and outside of affected areas and have had significant negative impacts on businesses and financial markets worldwide.

Due to theCOVID-19 pandemic, global air travel demand has precipitously declined, and resultant reduction in the number of flights scheduled by airlines caused by the pandemic has been sharply curtailed.begun to recover, but order demand from airlines for new deliveries of most aircraft models remains far below

pre-pandemic
levels. As the
COVID-19
pandemic impact on the air travel industry abates, the financial health of the airlines and airframe manufacturers is likely to remain stressed for some time, and the ultimate impact on the structure of the industry and the individual companies that comprise it is unknown. Because we are the primary source for aircraft cabin printers to the airframe manufacturers for a result,majority of aircraft models produced in the world, the longer-term demand for aircraftour products is defined less by the impact of
COVID-19
on particular airlines has declinedwithin the industry than the health of the industry as a whole. Although we do not know what the timing and is expectedrate of recovery will be, we do expect that the industry, and hence the demand for our products, will continue to remain lowerrecover slowly as the impact of effective vaccines become both widely available and accepted globally, and as demand for an unknown period, and thus manufacturers who make the airplanes that use our aerospace products have reduced their projected production rates across most or all of their product lines. air travel recovers.
Demand for aerospace spare products, paper, and parts and repairs has also been significantly impacted by the decline in air travel, demand. While the majoras requirements for these products and services are based primarily upon aircraft manufacturersusage. Although we have given some general statements to the public about their projected production rate changes that can be used to help align our overall production capacity,experienced modest increases in general, we produce products according to customer forecasts and order rates and at this time, the actual rates and timing of production requirements that will materialize is uncertain. The degree and duration of the decline in future demand for aircraftspare products, paper, parts and when and over what period any recovery will occur is still unknown. The decline in demand has had, andrepairs as flight hours have increased since the second quarter of fiscal 2021, we do not know the degree to which this will continue or increase, or at what pace.
22

While we have reduced our costs as much as we are prudently able to, have a material adverse impact on our revenues and results of operations until demand recovers. Our strategy and operational plans are to maintain sufficient capabilities and staffing to satisfy demand asfully support our customers and when it occurs, while prudently adjusting costs as appropriate inmeet the interim.

TheCOVID-19 pandemic has also had an adverse impact onstringent quality requirements the sales of our Product Identification hardware products due to travel restrictions, because, in most, cases customers preferin-person demonstrations of these printers at their production sites prior to placing orders with usmarket requires, and those visits have been severely limited. Additionally, the widespread cancellation of trade shows, which traditionally provided an effective forum for customers to consider our products, has also had an adverse impact. A greater reliance on remote video demonstrations, sample deliveries and digital marketing has proven effective in obtaining sales, but at a lower level than traditional methods. We expect that, while our customers’ acceptance of remote methods in their buying processes may have changed permanently, the degree to which that will prove to be the case once the currentCOVID-19 crisis has abated is unknown. Despite favorable market reception to our recently refreshed and expanded product lines, we expect that the level of hardware sales will remain lower until it is possible for our direct sales force and distributors to travel to visit customers and attend and present products at trade shows. The same dynamic has also affected our Test and Measurement product lines.

Shortly after theCOVID-19 crisis began, we experienced a somewhat greater demand for ink, toner, media and parts supplies that are used in our digital label printers. In addition to the strong demand from our food & beverage customers, we have also seen increased demand coming from customers selling products that have experienced higher demand as a result of the COVID-19 crisis, such as, certain medical, janitorial and sanitation related products. We do not know how long this trend will continue. However, although we have had to occasionally extend our lead times because of some temporary labor shortages, we have been able to adjustrapidly increase production and satisfyas demand returns, the decline in revenue has adversely impacted our customer demands successfully, and being a reliable supplier is one of the characteristics on which we compete.

Since theCOVID-19 pandemic began to impact us in early March, we have closely monitored the government and health authority recommendations applicable to us and have made modifications to our operations including requiring mostnon-production related team members to work remotely. While some inefficiencies related to remote work have occurred, overall effectiveness and productivity has been satisfactorily maintained. At the same time we have maintained sufficient capacity and employment levels in our manufacturing facilities located in West Warwick, Rhode Island, as well as in our manufacturing facilities in Canada and Germany to satisfy customer demand and related contractual commitments, despite a higher than normal level of absenteeism due to the ancillary impacts of the pandemic. We believe that as a result of a variety of heightened cleaning and sanitization standards, as well as several new health and safety protocols, procedures and workplace modifications implemented to safeguard our team members, the incidence ofCOVID-19 disease among our employees has thus far been limited. We know of only one case ofCOVID-19 among our teammates, and that individual returned to work, after completing the required quarantine period. Though the government mandatedCOVID-19 restrictions have begun to lessen in Rhode Island where our main production and office is located , if theCOVID-19 crisis were to worsen it could have further material adverse impacts on our ability to maintain workforce levels, productivity and output. As a result, we are maintaining current precautions for the near-term.

In response to theCOVID-19 pandemic and related economic dislocation, we are pursuing a variety of expense reduction and cash preservation initiatives. In connection with that effort, on April 27, 2020, our board of directors decided to suspend our quarterly cash dividend beginning with the second quarter of our fiscal year 2021. We have also reduced our direct labor staffing levels modestly in response to theCOVID-19 crisis, while maintaining levels sufficient to compensate for inefficiencies and disruptions resulting from the implementation ofCOVID-19-related health and safety protocols and, in our Product Identification supplies business, to satisfy customer demand. Many of the expenses related to our aerospace product lines cannot be easily reduced because of the continued need to support our existing customers and to provide the required sales, engineering, quality, and regulatory compliance and audit activities (among others) necessary to support the demanding regulatory requirements for these product lines. We continue to monitor and examine our overall and product line-specific cost structures and customer demand patterns, and as time progresses and the near and longer-term business outlook becomes clearer, we may make additional adjustments to employment levels.

In addition to the reductions in demand for many of our products and the workforce impacts caused by theCOVID-19 pandemic, we have also experienced some limited and temporary difficulties in obtaining raw materials and components for our products. These difficulties have had no meaningful negative impact on our production efficiency or our ability to satisfy customer requirements. However, more extensive and disruptive impacts may be experienced in the future, depending on how theCOVID-19 pandemic and its impacts on the economy evolve.

Disruptions in the capital markets as a result of theCOVID-19 outbreak have also adversely affected us, primarily because the bank lending market on which we depend has become more risk averse, leading to reduced availability of capital, higher loan pricing and less favorable terms. While we are currently negotiating the terms of an amendment to restructure our current credit facility with Bank of America, there can be no assurance that we will be successful in that negotiation or that the terms of any such restructured credit facility will be acceptable. If the negative impacts of theCOVID-19 pandemic continue for a prolonged period, or become worse, and we need additional liquidity, it could have a material adverse impact on our access to capital and financial position.

profitability.

Results of Operations

Three Months Ended May 1, 2021 vs. Three Months Ended May 2, 2020 vs. Three Months Ended May 4, 2019

Revenue by segment and current quarter percentage change over the prior year for the three months ended May 1, 2021 and May 2, 2020 and May 4, 2019 were:

(Dollars in thousands)

  May 2,
2020
   As a
% of
Revenue
  May 4,
2019
   As a
% of
Revenue
  % Change
Over
Prior Year
 

Product Identification

  $22,380    72.4 $23,591    65.2  (5.1)% 

T&M

   8,539    27.6  12,590    34.8  (32.2)% 
  

 

 

   

 

 

  

 

 

   

 

 

  

 

 

 

Total

  $30,919    100.0 $36,181    100.0  (14.5)% 
  

 

 

   

 

 

  

 

 

   

 

 

  

 

 

 

(Dollars in thousands)
  
May 1,
2021
   
As a
% of
Revenue
  
May 2,
2020
   
As a
% of
Revenue
  
% Change
Compared
to
Prior Year
 
Product Identification
  $23,098    79.4 $22,380    72.4  3.2
T&M
   5,980    20.6  8,539    27.6  (30.0)% 
  
 
 
   
 
 
  
 
 
   
 
 
  
 
 
 
Total
  $29,078    100.0  $30,919    100.0   (6.0)% 
  
 
 
   
 
 
  
 
 
   
 
 
  
 
 
 
Revenue for the first quarter of the current year was $30.9$29.1 million, representing a 14.5%6.0% decrease compared to the previous year first quarter revenue of $36.2$30.9 million. Revenue through domestic channels for the first quarter of the current year was $19.8$16.7 million, a decrease of 9.7%3.2% from the prior year’s first quarter. International revenue for the first quarter of the current year was $11.1$12.4 million, representing 36.0%42.6% of our first quarter revenue and reflects a 21.6% decreasereflecting an 11.3% increase from the previous year first quarter, primarily as a result of lower demand by a few customers in Asia in both the Product Identification and T&M segments.quarter. Current year first quarter international revenue includes an unfavorablea favorable foreign exchange rate impact of $0.2$0.8 million.

Hardware revenue in the current quarter was $8.9$7.6 million, a 31.0%14.2% decrease compared to the prior yearyear’s first quarter revenue of $12.9$8.9 million. The current quarter decrease can be attributedis attributable to both segments,the T&M segment, as hardware revenue for that segment decreased 33.6% in the T&M segment and 24.3% in the PI segment39.2% compared to the first quarter of the prior year. The T&M decrease in segment hardware sales resulted primarily from decreased aerospace printer product line sales. The decline in current quarter decreasehardware sales was partially offset by an overall 42.4% increase in hardware revenue in the T&M segment is primarily due to the decline in aerospace printer sales related to the Honeywell product lines. Also contributing to the current year first quarter revenue decline in the T&M segment, was the decrease in sales of other aerospace products, as well as a decrease in sales of data acquisition recorders. These declines are a result of the continued grounding of the Boeing 737 MAX, as well as the dramatic drop in air travel related to theCOVID-19 pandemic. Decreases in both QuickLabel and Trojan Label printer sales in the PI segment, which were impacted by travel and trade show restrictions, also contributed to theas well as an overall decline in hardware as sales from our new Trojan Three OPX printer were more than offset by declinesincrease in sales of QuickLabel’sQL-120,QL-300 andQL-800 and Trojan Label’sT2-Compact family of printers.

data recorders in the T&M product group.

Supplies revenue in the current quarter was $19.1$18.2 million, a 3.1%4.7% decrease fromcompared to the prior year’s first quarter supplies revenue of $19.7$19.1 million. The decrease in the current quarter supplies revenue as compared to the first quarter of the prior year is primarily attributable to alower ink jet and thermal film supplies revenue in the PI segment. The overall decrease in supplies revenue underwas also impacted to a lesser degree by a decline supplies revenue in the Honeywell Agreement. Also contributingT&M segment primarily related to declines in sales of printer supply products in the current quarteraerospace product group. The decline in suppliessupply revenue was the decrease inslightly offset by increased sales of Trojan Label product group ink jet supplies in the Product Identification segment due to a decline in sales to a key Asian customer. The decrease in supplies revenue for the current quarter was slightly offset by an increase in TrojanLabel product supplies revenue and certain categories of QuickLabel supplies within the Product Identification segment.

Service and other revenue was $2.9revenues of $3.3 million in the current quarter an 18.4% decrease from the prior yearincreased 11.5% compared to first quarter revenue of $3.5 million.$2.9 million in the prior year. The current quarter decreaseincrease is due primarily due to lowerincreased parts and repair revenue related toin the AstroNova aerospace printer product linesProduct Identification segment, as well as smaller increases in parts and repair revenue in the T&M segment and parts revenue in the QuickLabel product line in the PI segment.

Current year first quarter gross profit was $10.9 million, a 23.8% decrease compared toconsistent with the prior yearyear’s first quarter gross profit of $14.2 million. Our currentdespite the lower revenue. Current quarter gross profit margin of 35.1%37.4% reflects a430-basis 2.3 percentage point declineincrease from the prior year’s first quarter gross profit margin of 39.4%35.1%. The lowerhigher gross profit and related profit margin for the current quarter compared to the prior year’s first quarter is primarily attributable to decreased revenuelower manufacturing and unfavorable product mix in both the PI and T&M segments.

period costs.

Operating expenses for the current quarter were $10.2 million, a 13.4% decrease compared toconsistent with the prior yearyear’s first quarter operating expenses of $11.8 million. Specifically, currentexpenses. Current quarter selling and marketing expenses were $5.9$6.1 million, a 12.4%2.8% increase compared to the first quarter of the prior year. The increase for the current quarter was primarily due to slight increases in employee wage and commission expenses, and outside service expenditures, offset to a large degree by decreased employee benefits expense. Current quarter general and administrative expenses were $2.3 million, comparable to the first quarter of the prior year. Research and development (“R&D”) expenses were $1.7 million in the current quarter, an 11.5% decrease compared to $6.8$1.9 million in the first quarter of the prior year. The decline wasyear primarily due to decreases in the current year in travelemployee wage and entertainment, advertisingbenefits and trade show expenditures, as well as decreases in employee benefit expenditures. General and administrative expenses for the current quarter were $2.3 million, a 22.4% decrease as compared to $3.0 million in the prior year first quarter. The decline in current quarter general and administrative expenses was primarily due to decreases in professional fees, travel and entertainment and employee benefit expenditures, slightly offset by an increase in outside services and an allowance for doubtful accounts, which was partially driven by customer collection concerns stemming fromCOVID-19. Research and development (“R&D”) expenses of $1.9 million declined 3.3% from the first quarter of the prior year R&D expenses of $2.0 million.expenses. R&D spending as a percentage of revenue for the current quarter of 6.3% increasedwas 5.9% as compared to 5.5% of revenue in6.3% for the same period ofin the prior year.

Other expense in the first quarter of fiscal 2021the current year was $0.3 million, compared to other expense of $0.4 million, forconsistent with the first quarter of the prior year. Current quarter other expense includes interest expense on debt and the PPP loan of $0.2 million and $0.2 million of net foreign exchange loss. Other expense for the first quarter of the prior year also consisted primarily includesof interest expense on our debt and revolving line of credit of $0.2 million and $0.2 million of net foreign exchange lossloss.
23

We recognized a federal, state and foreign income taxestax benefit for the first quarter of the current year is $0.1 million,of $227,000, resulting in ana negative effective tax rate of 62.0%. This rate was impacted by a $276,000 tax benefit related to the expiration of the statute of limitations on a previously uncertain tax position and a $37,000 tax benefit arising from windfall tax benefits related to the Company’s stock. This compares to the prior year’s first quarter income tax benefit of $118,000, with a resulting negative effective tax rate of 37.6%. This rate was impacted by a reduction in internally forecasted operating results for our fiscal 2021 and a $78 thousand$78,000 tax benefit related to the expiration of the statute of limitations on previously uncertain tax positions. This compares to the prior year’s first quarter tax provision of $0.4 million, which reflected a $53 thousand benefit related to the expiration of the statute of limitations on a previously uncertain tax position, and a $97 thousand windfall tax benefit related to our stock, represented and representing an effective tax rate of 19.0%.

The Company

We reported net income of $0.4$0.6 million or $0.06$0.08 per diluted share for the first quarter of the current year. On a comparable basis, net income for the prior year’s first quarter was $1.7$0.4 million or $0.23$0.06 per diluted share. Return on revenue was 2.0% for the first quarter of fiscal 2022 compared to 1.4% for the first quarter of fiscal 2021 compared to 4.7% for the first quarter of fiscal 2020.

2021.

Segment Analysis

We report two segments: Product Identification and Test & Measurement and evaluate segment performance based on the segment profit before corporate and financial administration expenses. Summarized below are the Revenue and Segment Operating Profit (Loss) for each reporting segment:

   Three Months Ended 
   Revenue   Segment Operating Profit (Loss) 

(In thousands)

  May 2,
2020
   May 4,
2019
   May 2,
2020
  May 4,
2019
 

Product Identification

  $22,380   $23,591   $3,146  $2,886 

T&M

   8,539    12,590    (156  2,581 
  

 

 

   

 

 

   

 

 

  

 

 

 

Total

  $30,919   $36,181    2,990   5,467 
  

 

 

   

 

 

    

Corporate Expenses

       2,327   2,999 
      

 

 

  

 

 

 

Operating Income

       663   2,468 

Other Expense, Net

       (349  (368
      

 

 

  

 

 

 

Income Before Income Taxes

       314   2,100 

Income Tax (Benefit) Provision

       (118  400 
      

 

 

  

 

 

 

Net Income

      $432  $1,700 
      

 

 

  

 

 

 

   
Three Months Ended
 
   
Revenue
   
Segment Operating Profit
(Loss)
 
(In thousands)
  
May 1,
2021
   
May 2,
2020
   
May 1,
2021
  
May 2,
2020
 
Product Identification
  $23,098   $22,380   $2,729  $3,146 
T&M
   5,980    8,539    350   (156
  
 
 
   
 
 
   
 
 
  
 
 
 
Total
  $29,078   $30,919    3,079   2,990 
  
 
 
   
 
 
    
Corporate Expenses
     2,344   2,327 
    
 
 
  
 
 
 
Operating Income
     735   663 
Other Expense, Net
     369   349 
    
 
 
  
 
 
 
Income Before Income Taxes
     366   314 
Income Tax Benefit
     (227  (118
    
 
 
  
 
 
 
Net Income
    $593  $432 
    
 
 
  
 
 
 
Product Identification

Total current quarter revenue

Revenue from the Product Identification segment increased 3.2% in the first quarter of the current year, with revenue of $23.1 million compared to $22.4 million decreased 5.1% compared toin the same period of the prior year. The current quarter declineincrease in revenue is primarily due to decreases in hardware and supplies revenue within the QuickLabel product group as well as a declinenet increase in hardware revenue, in the TrojanLabel product group. The decline in QuickLabel revenue for the current quarter was primarily due to a decline in ink jet supply sales for a key Asian customer, as well as lower hardware sales impactedaided by travel and tradeshow restrictions as a result of theCOVID-19 pandemic. The current quarter decline in revenue was partially offset by increasedstrong sales of the new TrojanLabel product supplies and QuickLabel media supplies.
T3-OPX
printer. Product Identification’s current quarter segment operating profit was $3.1$2.7 million, reflecting a profit margin of 14.1%11.8%. This compares to the prior year’s first quarter segment profit of $2.9$3.1 million and related profit margin of 12.2%14.1%. Despite theThe decrease in revenue, Product Identification current year first quarter segment operating profit and margin increased compared to prior yearis primarily due to lowerhigher operating costs.

Test & Measurement—T&M

Revenue from the T&M segment was $8.5$6.0 million for the first quarter of the current fiscal year, representing a 32.2%30.0% decrease compared to revenue of $12.6$8.5 million for the same period in the prior year. The decrease in revenue for the current yearquarter is primarily attributable to the continued decline in sales of hardware in our aerospace product lines as a result of the Boeing 737 MAX grounding and also the severe drop in demand for new aircraft related to the dramatic dropdecline in air travel due to the impact of
COVID-19. Also contributing to the decline in revenue for this segment were decreased hardware product sales for T&M data recorders and AstroNova aerospace products for programs other than the 737 MAX as a result of the drop in air travel due to the impact of COVID-19. The T&M segment also experienced a decrease in supplies and parts revenue in the aerospace product line in the current quarter.
T&M’s first quarter segment operating lossprofit was $0.2$0.4 million, resulting inreflecting a negative 1.8% profit margin of 5.9%, an increase compared to the prior year segment operating profitloss of $2.6$0.2 million and related negative operating margin of 20.5%1.8%. Although operating costs were reduced,Despite lower sales revenue in the decreasecurrent quarter, the increase in sales and related product mix resulted in lower segment operating profit and related margin for the current period.

were primarily due to lower period and operating costs, along with slightly better sales mix.

24

Financial Condition and Liquidity

Overview

Historically, our primary sources of short-term liquidity have been cash generated from operating activities and borrowings under our revolving credit facility. These sources have also usually funded a portionthe majority of our capital expenditures and contractual contingent consideration obligations. We have funded acquisitions by borrowing under bank term loan facilities. However, as the result of the decline in demand for our products, especially with respect to the 737 MAX specifically and in the aerospace market more generally as the result of theCOVID-19 pandemic, it is likely that we will have to rely more heavily on external financing sources to meet our operating and capital needs until market conditions allow for our earnings and cash flow generation capabilities to improve or we are able to reduce costs sufficiently to generate more earnings and cash flow.

Conditions have deteriorated in the credit markets generally and in the bank financing market specifically, and the availability of credit has been reduced as a result of lending institutions taking a more conservative posture in response to the risks introduced by theCOVID-19 pandemic. Because of the deterioration of our financial condition due to the decline in 737MAX-related revenue andCOVID-19 impacts, our first quarter operating results caused us to violate a financial covenant in our Credit Agreement with Bank of America. Specifically, under the terms of our current Credit Agreement we are obligated to maintain, as of the end of each fiscal quarter, a minimum EBITDA (as defined in the agreement) of $9.5 million on a trailing twelve-months basis and a maximum consolidated leverage ratio of 3.0 to 1.0. Our actual EBITDA was below the required level for the period ended May 2, 2020. However, on June 22,

On July 30, 2020, we entered into a letter agreementan Amended and Restated Credit Agreement (the “A&R Credit Agreement”) with the Bank of America, N.A. (the “Letter Agreement”“Lender”), wherein Bank of America agreed to waive compliance with both of those financial covenants for the measurement period ended May 2, 2020.our wholly owned subsidiary ANI ApS, a Danish private limited liability company and ANI ApS’s wholly-owned subsidiary TrojanLabel ApS, a Danish private limited liability company (“TrojanLabel”). The LetterA&R Credit Agreement requires us to have, as of June 30, 2020, consolidated EBITDA of not less than $9.5 million on a trailing twelve-months basis,amended and to report our compliance with such covenant on or before August 15, 2020. The Letter Agreement provides that such covenant will not be tested until August 15, 2020 and we do not expect to be in compliance with the covenants at the time, hence constituting an immediate event of default under the Credit Agreement. However, we and Bank of America are actively negotiating the terms of an amendment to restructurerestated the Credit Agreement that would providedated as of February 28, 2017 by and among us, ANI ApS, TrojanLabel and the Lender. In connection with our entry into the A&R Credit Agreement, we entered into an Amended and Restated Security and Pledge Agreement and a mortgage in favor of the Lender with respect to our owned real property in West Warwick, Rhode Island. Under the A&R Credit Agreement, AstroNova, Inc. is the sole borrower, and its obligations are guaranteed by ANI ApS and TrojanLabel.
On March 24, 2021, we entered into a First Amendment to Credit Agreement (the “Amendment”) to our A&R Credit Agreement (the “A&R Credit Agreement amended by the Amendment, the “Amended Credit Agreement”) with the Lender, ANI ApS and TrojanLabel. Immediately prior to the closing of the Amendment, we repaid $ 2.6 million in principal amount of the term loan outstanding under the A&R Credit Agreement, resulting in an outstanding balance of the term loan of $10.0 million and no amount drawn and outstanding under the revolving credit facility under the Amended Credit Agreement.
The Amended Credit Agreement expires on September 30, 2025, a significant extension of tenor. It also eliminated a minimum adjusted EBITDA covenant, an asset coverage covenant and a minimum liquidity covenant, and, subject to ongoing covenant compliance, significantly reduced limitations on restricted payments such as dividends, eliminated restrictions on capital expenditures and increased operating flexibility with respect to funding our global operations.
25

The Amended Credit Agreement provides for mutually acceptable revised financial(i) a term loan in the principal amount of $10.0 million, and operational covenants and other mutually acceptable revised terms and(ii) a $22.5 million revolving credit facility available for general corporate purposes. At the closing of the Amended Credit Agreement, we both fully expect that amendmentborrowed the entire $10.0 million term loan which was used to refinance in full the outstanding term loan under the A&R Credit Agreement. Under the Amended Credit Agreement, revolving credit loans may continue to be executed priorborrowed, at our option, in U.S. Dollars or, subject to August 15, 2020. The effectcertain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner.
While we have expected that as a result of the Letter Agreement therefore is to give both parties sufficient time to complete the relevant documentation and also enable us to execute the amendment by that deadline.

If for any reason we are unable to reach agreement with Bank of America on the restructuringimpact of the Credit Agreement or secure alternative financing on acceptable terms prior to August 15, 2020, and the Letter Agreement were not extended or otherwise modified to eliminate any failure by us to comply with its terms or the terms of the Credit Agreement, Bank of America would have the right to declare a default, accelerate all

COVID-19
pandemic, some of our outstanding indebtedness under the Credit Agreementcustomers would experience liquidity pressure and demand payment thereof, which demand we would be unable to satisfy. pay us for products on a timely basis, in general our recent receivables collection experience has been consistent with our historical experience and a significant deterioration in receivables collection has not occurred.
In addition, any default underresponse to the Credit Agreement that would permit Bank
COVID-19
pandemic and related economic dislocation, we have implemented and will continue to implement a variety of America to accelerate the repaymentexpense reduction and cash preservation initiatives. On April 27, 2020, our board of the indebtedness outstanding under that facility would also constitute a default under the PPP Loan and cause the indebtedness outstanding thereunder to become immediately payable. If any of the foregoing were to occur, it would have a material adverse impact on us.

Under the terms of the Letter Agreement, we are also not permitted to request any additional borrowings under the revolving line of credit through August 15, 2020, and we will not be permitted to request any such additional borrowings thereafter unless we are in compliancedirectors suspended our quarterly cash dividend beginning with the Credit Agreement. The Letter Agreement also prohibits us from making any dividend or stock repurchase payments or other restricted payments through August 15, 2020, and we will be permitted to make restricted payments thereafter only in compliance with the Credit Agreement.

During the firstsecond quarter of the currentour fiscal year we borrowed an additional $5.0 million on our revolving credit facility, and at2021.

At May 2, 2020 we had $11.5 million of borrowings outstanding under that facility. On May 2, 2020,1, 2021, our cash and cash equivalents were $11.1$11.4 million. There was no outstanding balance on our revolving line of credit at May 1, 2021 and we have $22.5 million and at that date we had $6.0 million remaining available for borrowing under that facility. We believe that our available cash and credit facilities combined with our cash generated from operations will be sufficient to support our operating requirements, so long as the impact of
COVID-19
does not worsen.
Indebtedness
Term Loan
The Amended Credit Agreement requires that the term loan be paid as follows: the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2021 through January 31, 2022 is $187,500; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2022 through January 31, 2023 is $250,000; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2023 through January 31, 2025 is $312,500; the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about April 30, 2025 and July 31, 2025 is $500,000; and the entire remaining principal balance of the term loan is required to be paid on September 30, 2025. We may voluntarily prepay the term loan, in whole or in part, from time to time without premium or penalty (other than customary breakage costs, if applicable). We may repay borrowings under the revolving credit facility. Pursuant tofacility at any time without premium or penalty (other than customary breakage costs, if applicable), but in any event no later than September 30, 2025, at which time any outstanding revolving loans will be due and payable in full, and the terms of the Fourth Amendment to the Credit Agreement, which we and Bank of America entered into in December 2019, the aggregate amount available for borrowings underrevolving credit facility will terminate. We may reduce or terminate the revolving line of credit will decreaseat any time, subject to $10.0 million atcertain thresholds and conditions, without premium or penalty.
The Amended Credit Agreement includes an uncommitted accordion provision under which the endterm loan and/or revolving credit facility commitments may be increased in an aggregate principal amount not exceeding $10,000,000, subject to obtaining the agreement of the third quarterLender and the satisfaction of fiscal 2021.certain other conditions.
As under the A&R Credit Agreement, the loans under the Amended Credit Agreement are subject to certain mandatory prepayments, subject to various exceptions, from (a) net cash proceeds from certain dispositions of property, (b) net cash proceeds from certain issuances of equity, (c) net cash proceeds from certain issuances of additional debt and (d) net cash proceeds from certain extraordinary receipts.
Amounts repaid under the revolving credit facility may be reborrowed, subject to continued compliance with the Amended Credit Agreement. No amount of the term loan that is repaid may be reborrowed.
The interest rates under the A&R Credit Agreement were modified in the Amended Credit Agreement as follows: the term loan and revolving credit loans bear interest at a rate per annum equal to, at our option, either (a) the LIBOR Rate as defined in the A&R Credit Agreement (or in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.60% to 2.30% based on our consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal fund rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate, (iii) the LIBOR Rate plus 1.00% or (iv) 0.50%, plus a margin that varies within a range of 0.60% to 1.30% based on our consolidated leverage ratio. In addition to certain other fees and expenses that we are required to pay to the Lender, we are required to pay a commitment fee on the undrawn portion of the revolving credit facility that varies within a range of 0.15% and 0.30% based on our consolidated leverage ratio.
We must comply with various customary financial and
non-financial
covenants under the Amended Credit Agreement. The financial covenants under the Amended Credit Agreement consist of a maximum consolidated leverage ratio and a minimum consolidated fixed charge coverage ratio. The minimum EBITDA, minimum consolidated asset coverage ratio, minimum liquidity and maximum capital expenditures covenants with which we were required to comply under the A&R Credit Agreement were eliminated
26

by the Amendment. The primary
non-financial
covenants limit our and our subsidiaries’ ability to incur future indebtedness, to place liens on assets, to pay dividends or distributions on their capital stock, to repurchase or acquire their capital stock, to conduct mergers or acquisitions, to sell assets, to alter their capital structure, to make investments and loans, to change the nature of their business, and to prepay subordinated indebtedness, in each case subject to certain exceptions and thresholds as set forth in the Amended Credit Agreement, certain of which provisions were modified by the Amendment.
The Lender is entitled to accelerate repayment of the loans and to terminate its revolving credit commitment under the Amended Credit Agreement upon the occurrence of any of various customary events of default, which include, among other events, the following (which are subject, in some cases, to certain grace periods): failure to pay when due any principal, interest or other amounts in respect of the loans, breach of any of our covenants or representations under the loan documents, default under any other of our or our subsidiaries’ significant indebtedness agreements, a bankruptcy, insolvency or similar event with respect to us or any of our subsidiaries, a significant unsatisfied judgment against us or any of our subsidiaries, or a change of control.
Our obligations under the Amended Credit Agreement continue to be secured by substantially all of our personal property assets (including a pledge of the equity interests held by us in ANI ApS, in our wholly-owned German subsidiary AstroNova GmbH, and in our wholly-owned French subsidiary AstroNova SAS), subject to certain exceptions, and by a mortgage on our owned real property in West Warwick, Rhode Island. Pursuant to the Letter Agreement, we are not permitted to request any additional borrowingsAmendment, the guarantees of our obligations under the revolving line of credit through August 15, 2020.

A&R Credit Agreement that were previously provided by ANI ApS and TrojanLabel were released.

PPP Loan
On May 6, 2020, we entered into a Loan Agreement with and executed a promissory note in favor of Greenwood Credit Union (“Greenwood”) pursuant to which we borrowed $4.4 million (the “PPP Loan”) from Greenwood pursuant to the Paycheck Protection Program (the “PPP”) administered by the United States Small Business Administration (the “SBA”) and authorized by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), enacted on March 27, 2020.

The terms of the PPP Loan were subsequently revised in accordance with the provisions of the Paycheck Protection Flexibility Act of 2020 (the “PPP Flexibility Act”), which was enacted on June 5, 2020.

We believe that our obtaining the PPP Loan and suspending the payment of dividends on our common stock were instrumental in our ability to successfully negotiate the A&R Credit Agreement.

The PPP Loan, which will mature on the fifth anniversary of the date on which we submit our request for forgiveness with respect to the PPP Loan,May 6, 2022, is unsecured and bears interest at a rate of 1.0% per annum. annum, accruing from the loan date and is payable monthly. No payments are due on the PPP Loan at this time, but interest accrues during the deferral period. Interest accrued in the amount of $44,000 has been accrued through May 1, 2021.
The PPP Loan may be prepaid at any time without penalty. The Loan Agreement and Promissory Note include customary provisions for a loan of this type, including prohibitions on our payment of dividends or repurchase of shares of our stock while the PPP Loan remains outstanding and events of default relating to, among other things, payment defaults, breaches of the provisions of the Loan Agreement or the Promissory Note and cross-defaults on other loans.

Subject to the limitations and conditions set forth in the CARES Act, the PPP Flexibility Act and the regulations and guidance provided by the SBA with respect to the PPP, a portion of the PPP Loan may be forgiven in an amount up to the amount of the PPP Loan proceeds we spendspent on payroll, rent, utilities and interest on certain debt during the twenty-four week period following incurrence of the PPP Loan; interest accrued on the forgiven portion of the principal amount of the PPP Loan may be forgiven under the PPP.is also forgiven. The amount of the PPP Loan to be forgiven in respect of rent, utilities and interest on certain debt will be capped at 40% of the forgiven amount, with the remaining forgiven amount allocated to payroll costs. We intend to applyIn fiscal 2021, we fully utilized the PPP Loan proceeds for qualifying expenses and have applied for forgiveness of the PPP Loan. However, no assurance can be provided thatLoan (including all or any portion of the PPP Loan will be forgiven.

As a result of the impact of theCOVID-19 pandemic, our customers may also experience liquidity pressure and be unable to pay us for products on a timely basis. During the first quarter we experienced a limited number of casesassociated accrued interest) in which certain of our aerospace customers failed to pay us on a timely basis and we increased our reserves for potential losses on those accounts. We also wrote off a small receivable from an airline that has declared bankruptcy. If the impact of theCOVID-19 crisis continues for a prolonged period of time or worsens, we may experience further similar, but more material adverse impacts on our results and financial condition.

Our backlog decreased 2.8% fromyear-end to $25.9 million at the end of the first quarter of fiscal 2021.

Indebtedness

We andthe current year. Whether our wholly owned Danish subsidiaries, ANI ApS and TrojanLabel ApS (collectively, the “Parties”), are parties to a credit agreement (“Credit Agreement”) with Bank of America, N.A. The Credit Agreement and its subsequent amendments through fiscal 2019 providedapplication for a secured credit facility consisting of a term loan to ANI ApS in the principal amount of $9.2 million, a term loan to us in the principal amount of $15.0 million and a $10.0 million revolving credit facility. On December 9, 2019, the Parties entered into a Fourth Amendment (the “Fourth Amendment”) to the Credit Agreement. The Fourth Amendment amended the Credit Agreement to, among other things, (i) increase the aggregate amount available to us for borrowings under the revolving line of credit from $10.0 million to $17.5 million through the third quarter of fiscal 2021 and (ii) modify the financial covenants with which we must comply thereunder by excluding certain capital expenditures from the calculation of our consolidated fixed charge coverage ratio, providing that the minimum consolidated fixed charge coverage ratio covenantforgiveness will be suspended through the second quarter of fiscal 2021,granted and adding a minimum consolidated EBITDA covenant commencing with the fourth quarter of fiscal 2020 and continuing through the second quarter of fiscal 2021.

See Note 17 of the condensed consolidated financial statements included in this Quarterly Report on Form10-Q for a discussion of the letter agreement we entered into with Bank of America on June 22, 2020, which, among other things, suspends our access to the revolving line of credit under the Credit Agreement on the terms described therein.

Both term loans bear interest at a rate per annum equal to the LIBOR rate plus a margin that varies within a range of 1.0% to 1.5% based on our consolidated leverage ratio.

In connection with our entry into the Credit Agreement, ANI ApS entered into a hedging agreement to manage the variable interest rate risk and currency risk associated with its payments in respect to the term loan. Under this combined arrangement, payments of principal and interest with respect to approximately $8.9 million of the principal of the term loan will be made in Danish Kroner, and interest on such principalwhat amount will be payable at a fixed rate of 0.67% per annum for the entire term, subject only to potential changes based on our consolidated leverage ratio. Additionally, we entered into a hedging agreement to manage the variable interest rate risk associated with our payments with respect to the $15.0 million term loan. Under this combined arrangement, interest will be payable at a fixed rate of 2.04% per annum for the entire term, plus an incremental margin of 1.0% to 1.5%, based on our consolidated leverage ratio.

Revolving credit loans may be borrowed, at our option, in U.S. Dollars or,is subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner. Amounts borrowed underan application to, and approval by, the revolving credit facility bear interest at a rate per annum equal to, at our option, either (a) the LIBOR rate (or, in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.0% to 1.5% based on our consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal funds’ rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate or (iii) the LIBOR rate plus 1.00%, plus a margin that varies within a range of 0.0% to 0.5% based on our consolidated leverage ratio. We are required to pay a commitment fee on the undrawn portion of the revolving credit facility at the rate of 0.25% per annum. Outstanding borrowings under the revolving credit line during fiscal 2020 bear interest at a weighted average annual rate of 2.52%SBA and we paid $73,000 of interest expense for revolving credit line borrowings for the three months ended May 2, 2020.

The obligations of ANI ApS in respect of the $9.2 million term loan are guaranteed by us and TrojanLabel ApS. Our obligations in respect of the $15.0 million term loan, revolving credit facility and its guarantee in respect of the ANI ApS term loan are secured by substantially all of our assets (including a pledge of a portion of the equity interests we hold in ANI ApS and our wholly owned German subsidiary, AstroNova GmbH),may also be subject to certain exceptions.

The Lender is entitled to accelerate repayment offurther requirements in any regulations and guidelines the loans and to terminate its revolving credit commitment under the Credit Agreement upon the occurrence of any of various customary events of default.

The Parties must comply with various customary financial andnon-financial covenants under the Credit Agreement.

We would not comply with certain financial covenants in the amended Credit Agreement if Bank of America had not agreed to waive compliance with those covenants pursuant to the Letter Agreement we entered into with Bank of America on June 22, 2020. We and Bank of America are actively negotiating the terms of an amendment to restructure the Credit Agreement that would provide for mutually acceptable revised financial and operational covenants and other mutually acceptable revised terms; however, no assurance can be given that we will succeed in this effort. If we are successful in negotiating the terms of this amendment, we expect the amended Credit Agreement to provide for, among other things, substantial changes to the structure of the credit facility as it relates to the loans currently outstanding thereunder that were borrowed by AstroNova, Inc.’s subsidiary TrojanLabel ApS. We expect that all loans under the amended Credit Agreement would be direct obligations of AstroNova, Inc. We also expect that the amended Credit Agreement would prohibit our paying dividends on or repurchasing our capital stock and making certain other restricted payments.

SBA may adopt.

Cash Flow

Our statements of cash flows for the three months ended May 2, 20201, 2021 and May 4, 20192, 2020 are included on page 87 of this report. Net cash provided by operating activities was $3.4$3.9 million for the first quarterthree months of fiscal 20212022 compared to $1.0$3.4 million for the same period of the previous year. The increase in net cash provided by operations for the first three months of the current year is primarily due to the decreaseincrease in cash used forprovided by working capital. The combination of changes in accounts receivable, inventory, income taxes payable, accounts payable and accrued expenses providedincreased cash of $1.2by $1.8 million for the first three months of fiscal 2021,2022, compared to $3.1an increase of $1.2 million of cash used for the same period in fiscal 2020.

2021.

Our accounts receivable balance decreased to $18.5$15.2 million at the end of the first quarter compared to $19.8$17.4 million at year end. The $1.3 million decrease in the accounts receivable balance from year end is directly related to the decrease in sales for the first quarter of the current year. Days sales outstanding for the first quarter of the current year was 54also declined to 47 days compared to 5551 days at prior year end.

Our The decline in the accounts receivable balance and days sales outstanding in the first quarter of the current year is largely due to the

27

increase in PI product sales, which tend to have shorter collection cycles, as well as a few large payments received on account from aerospace customers.
The inventory balance was $32.6$29.5 million at the end of the first quarter of fiscal 2021,2022, a small decline compared to $33.9$30.1 million at year end and inventoryend. Inventory days on hand decreased to 146 days at the end of the current quarter from 151147 days at the prior year end.
28

The current period decrease in inventory is directly related to a reduction in our forecasted operating results for fiscal 2021cash position remained consistent with year end at $11.4 million. Cash was primarily provided from the working capital accounts, as discussed above. Cash outflows and during the quarter included the refinancing of debt, which resulted in lower inventory purchasesa net outflow of cash of $2.6 million, principal payments on the new long-term debt and lower inventory needed in the Product Identification segment due to the prior yearbuild-up related to theQL-120 printer product.

The net increased cash position at May 2, 2020 primarily resulted from the contribution from cash provided by operations of $3.4 million, along with the $5.0 million borrowing under our revolving line of credit. This increase was slightly offset by payments of the guaranteed royalty obligation under the Honeywell Agreement of $0.2 million and $0.5 million, respectively, and cash used to acquire property, plant and equipment of $0.6 million, and payment of our quarterly dividend of $0.5 million.

Contractual Obligations, Commitments and Contingencies

There have been no material changes to our contractual obligations as disclosed in our Annual Report on
Form10-K
for the fiscal year ended January 31, 2020,2021 other than those which occuroccurring in the ordinary course of business.

Critical Accounting Policies, Commitments and Certain Other Matters

The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosure of commitments and contingencies at the date of the condensed consolidated financial statements and reported amounts of revenue and expenses during the reporting period. We base these estimates and judgments on factors we believe to be relevant, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

The process of determining significant estimates is fact-specific and takes into account factors such as historical experience, current and expected economic conditions, product mix, and in some cases, actuarial and appraisal techniques. We constantly
re-evaluate
these significant factors and make adjustments where facts and circumstances dictate.

While we believe that the factors considered provide a meaningful basis for the accounting policies applied in the preparation of the condensed consolidated financial statements, we cannot guarantee that our estimates and assumptions will be accurate. As the determination of these estimates requires the exercise of judgment, actual results may differ from those estimates, and such differences may be material to our condensed consolidated financial statements. There have been no material changes to the application of critical accounting policies as disclosed in our Annual Report on Form
10-K
for the fiscal year ended January 31, 2020.

2021.

Forward-Looking Statements

This Quarterly Report on Form
10-Q
may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Factors which could cause actual results to differ materially from those anticipated include, but are not limited to (a) general economic, financial and business conditions; (b) the impact of the ongoing
COVID-19
pandemic on us, our customers, our suppliers and the global economy; (b) general economic, financial and business conditions; (c) declining demand in the test and measurement markets, especially defense and aerospace; (d) competition in the specialty printer industry; (e) our ability to develop and introduce new products and achieve market acceptance of these products; (e) difficulties encountered in connection with the certification of the 737 MAX for return to service; (f) our dependance on contract manufactures and/or single or limited source suppliers; (g) competition in the specialty printer or data acquisition industry; (g)industries; (h) our ability to obtain adequate pricing for our products and control our cost structure; (i) our ability to adequately enforce and protect our intellectual property, defend against assertions of infringement or loss of certain licenses; (j) the risk of a material security breach of our information technology system or cybersecurity attack impacting our business and our relationship with customers; (k) any technology disruption or delay in implementing new technology or our new global ERP system; (l) our ability to attract, develop and retain key employees; (m) economic, political and other risks associated with international sales and operations and the impact of changes in foreign currency exchange rates on the results of operations; (h) the(n) changes in tax rates or exposure to additional income tax liabilities; (o) our ability to comply with our current credit agreement or secure alternative financing and to otherwise manage our indebtedness; (p) our ability to successfully integrate acquisitions and realize benefits from divestitures; (i)(q) our ability to restructure the terms ofmaintain adequate self-insurance accruals or insurance coverage for employee health care benefits; (r) our current credit facility and to otherwise manage our indebtedness; (j) our ability to obtain financing for working capital and capital expenditures; (k) the business abilities and judgment of personnel and changes in business strategy; (l) the efficacy of research and development investments to develop new products; (m) the launching of significant new products which could result in unanticipated expenses; (n) bankruptcycompliance with customer or other financial problems at major suppliers or customers that could cause disruptions in our supply chain or difficulty in collecting amounts owed by such customers; (o) any technology disruption or delay in implementing new technology; (p) a material security breach or cybersecurity attack impacting our businessregulators certifications and our relationshipcompliance with customerscertain governmental laws and (q)regulations; and (s) other risks included under
“Item 1A-Risk
Factors” in our Annual Report on Form
10-K
for the fiscal year ended January 31, 2020.2021. We assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

29

Item
3.

Quantitative and Qualitative Disclosures About Market Risk

During the three months ended May 2, 2020,1, 2021, there were no material changes to our market risk disclosures as set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form
10-K
for the year ended January 31, 2020.

2021.

Item
4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management has evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report pursuant to
Rule 13a-15(b)
under the Securities Exchange Act of 1934, as amended (Exchange Act). Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to have materially affected, our internal control over financial reporting. We have not experienced any material impact to our internal controls over financial reporting despite the fact that most of ournon-production employees are working remotely due to theCOVID-19 pandemic. We are continually monitoring and assessing theCOVID-19 situation with respect to our internal controls to minimize the potential impact on their design and operational effectiveness.

PART II. OTHER INFORMATION

Item
1.

Legal Proceedings

There are no pending or threatened legal proceedings against us that we believe to be material to our financial position or results of operations.

Item
1A.

Risk Factors

This section augments and updates certain risk factors disclosed in Item 1A of Part I of our Annual Report on Form10-K for the year ended January 31, 2020 (the “Annual Report”). We are providing the following information regarding changes that have occurred to the previously disclosed risk factors in our Annual Report onForm 10-K.

In addition to the other information set forth in this Quarterly Report on Form
10-Q, all risk
one should carefully consider the factors should be carefully considereddiscussed in evaluating us and our common stock. Any of these risks, many ofPart I, Item 1A “Risk Factors” in the Company’s Annual Report on Form
10-K
for the fiscal year ended January 31, 2021, which are beyond our control, could materially and adversely affect our business, financial condition results of operations or cash flows, or causefuture operating results. The risks described in our actual results to differ materially from those projected in any forward-looking statements. We may also face otherAnnual Report on
10-K
are not the only risks that could affect our business, as additional risks and uncertainties that are not presently known, are not currently believedknown to us or that we currently deem to be material, or are not identified below because they are common to all businesses. Past financial performanceimmaterial also may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. For more information, see “Forward-Looking Statements” elsewhere in this Quarterly Report.

The ongoingCOVID-19 pandemic has adversely affected and will likely continue to adversely affect our revenues, results of operations and financial condition.

Our business has been and will likely continue to be materially adversely affected by the widespread outbreak of contagious disease, including the recent outbreak of respiratory illness caused by a novel coronavirus known asCOVID-19.COVID-19 has been declared by the World Health Organization to be a “pandemic” and has spread to many of the countries in which we, our customers, our suppliers and our other business partners do business. National, state and local governments in affected regions have implemented and may continue to implement safety precautions, including quarantines, travel restrictions, business closures, cancellations of public gatherings and other measures. Other organizations and individuals are taking additional steps to avoid or reduce infection, including limiting travel and staying home from work. These measures are disrupting normal business operations both inside and outside of affected areas and have had significant negative impacts on businesses and financial markets worldwide.

We continue to monitor our operations and government recommendations and have made modifications to our normal operations because of theCOVID-19 outbreak, including requiring mostnon-production related team members to work remotely. We have maintained a substantial portion of our manufacturing operational capacity at our manufacturing facilities located in West Warwick, Rhode Island, as well as our manufacturing facilities in Canada and Germany, at this time, and we have instituted heightened cleaning and sanitization standards and several health and safety protocols and procedures to safeguard our team members. However, we have experienced a number of adverse impacts as a result of theCOVID-19 outbreak, including reductions in demand for our products, delays and cancellations of orders for our products, difficulties in obtaining raw materials and components for our products, shortages of labor to manufacture our products, inefficiencies caused by remote workers’ difficulties in performing their normal work outputs, closures of the facilities of some of our suppliers and customers, and delays in collecting accounts receivable.

While it is not possible at this time to estimate the full scope of the impact thatCOVID-19 will have on our business, customers, suppliers or other business partners, we expect that the continued spread ofCOVID-19, the measures taken by the governments of affected countries, actions taken to protect employees, and the impact of the pandemic on all business activities to further adversely impact our operational capacity and the efficiency of our team members and will continue to materially adversely affect our business, financial condition and/or operating results of operations and financial condition.

The adverse effect ofCOVID-19 on our business has negatively impacted our ability to comply with the covenants governing our credit facility, and disruptions in the credit and capital markets as a result ofCOVID-19 have and may continue towell as adversely affect the terms on which we are able to obtain new financing.

The aerospace industry, which we serve through our aerospace product line, has been significantly disrupted by theCOVID-19 outbreak, both inside and outside of the United States. The decline in air travel has had and will continue to have a material adverse impact on our financial results, the ultimate scope of which we cannot estimate at this time. Should one or morevalue of our airplane OEM manufacturing customers or a significant number of airline customers failcommon stock.

There have been no material updates to continue business as a going concern, declare bankruptcy, or otherwise reduce the demand for our products as a result of the impact of theCOVID-19 pandemic, it would have a material adverse impact on our business operations and financial results.

If we are unable to successfully negotiate an amendment to our credit agreement with Bank of America or secure alternative financing, our business and financial condition could be materially adversely affected.

Our credit agreement with Bank of America requires us, among other things, to satisfy certain financial ratios and conditions on an ongoing basis. Specifically, we are required to maintain minimum EBITDA (as definedrisk factors previously disclosed in the credit agreement) of $9.5 millionCompany’s Annual Report on a trailing twelve-months basis and our consolidated leverage ratio is not permitted to exceed 3.0 to 1.0, in each case as of the end of each fiscal quarter. Our actual EBITDA dropped below the required level for such period ended May 2, 2020, primarily as a result of the declines in our revenue attributable to the reduced demand for aircraft cockpit printers

Form 10-K
for the Boeing 737 MAX aircraft and the reduced demand for aircraft driven by the global reduction in air travel caused by theCOVID-19 outbreak. While we entered into a Letter Agreement with Bank of America on June 22, 2020 that, among other things, waived our noncompliance with the financial covenants in the credit agreement noted above for the measurement period ending May 2, 2020, the Letter Agreement requires us to have, as of June 30, 2020, a consolidated EBITDA of not less than $9.5 million on a trailing twelve month basis, and to report our compliance with such additional covenant on or before August 15, 2020. While we and Bank of America have agreed in the Letter Agreement that this additional covenant will not be tested until August 15, 2020, we do not expect to comply with this additional covenant when it is tested. If an event of default occurs with respect to our obligations under the credit agreement, Bank of America is entitled to declare all of our outstanding borrowings under the credit agreement immediately due and payable. In addition, the loan agreement governing our PPP Loan includes a cross-default provision whereby a default under other debt facilities could result in a default and acceleration of our repayment obligations under the PPP Loan. While we are actively negotiating an amendment to restructure the terms of our credit agreement with Bank of America, there can be no assurance that we will be able to successfully complete such amendment or secure alternative financing on acceptable terms or at all. If we are unable to renegotiate the terms of our credit agreement or secure alternative financing and Bank of America declares our outstanding borrowings immediately due and payable, we would be unable to satisfy that demand. If that occurred it would have a material adverse impact on us.

fiscal year ended January 31, 2021.

Item
2.

Unregistered Sales of Equity Securities and Use of Proceeds

During the first quarter of fiscal 2021,2022, we made the following repurchases of our common stock:

   Total Number
of Shares
Repurchased
  Average
Price paid
Per Share
  Total Number of
Shares Purchased as
Part of Publicly
Announced Plans
or  Programs
   Maximum Number
of Shares That
May Be Purchased
Under the Plans
or  Programs
 

February 1 – February 29

   —     —     —      —   

March 1 – March 31

   5,570(a)(b)  6.92(a)(b)  —      —   

April 1 – April 30

   —     —     —      —   

   
Total Number
of Shares
Repurchased
  
Weighted

Average
Price paid
Per Share
  
Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs
   
Maximum Number
of Shares That
May Be Purchased
Under the Plans
or Programs
 
February 1—February 28
   —    $—    —      —   
March 1—March 31,
   15,629 (a)(b) $13.32 (a) (b)   —      —   
April 1—April 30
   —    $—    —      —   
30

(a)

An executive

Executives of the Company delivered 4027,287 shares of the Company’s common stock toward the satisfaction of taxes due with respect to vesting of restricted shares. The shares delivered were valued at an average market value of $12.31 per share and are included with treasury stock in the consolidated balance sheet. These transactions were not part of a publicly announced purchase plan or program.
(b)
Executives of the Company delivered 8,342 shares of the Company’s common stock toward the satisfaction of taxes due with respect to vesting of restricted shares. The shares delivered were valued at a weighted-average market value of $9.38$14.20 per share and are included with treasury stock in the consolidated balance sheet. These transactions were not part of a publicly announced purchase plan or program.

(b)

Executives of the Company delivered 5,168 shares of the Company’s common stock toward the satisfaction of taxes due with respect to vesting of restricted shares. The shares delivered were valued at a weighted-average market value of $6.73 per share and are included with treasury stock in the consolidated balance sheet. These transactions were not part of a publicly announced purchase plan or program.

31

Item 5. Other Information

We are providing the following information under this Item 5 in lieuTable of reporting the information under Item 1.01, “Entry Into a Material Definitive Agreement,” of a Current Report on Form8-K with a due date on or after the date hereof:

On June 22, 2020, we entered into a Letter Agreement with Bank of America, N.A. relating to the testing of certain financial covenants included in the credit agreement dated as of February 28, 2017 between us, our wholly owned Danish subsidiaries, ANI ApS and TrojanLabel ApS and Bank of America, as amended to date. Pursuant to that agreement, Bank of America has agreed to waive the testing of the financial covenants set forth in the credit agreement related to our consolidated leverage ratio and consolidated EBITDA (as defined in the credit agreement) for the measurement period ending May 2, 2020. The Letter Agreement requires us to have, as of June 30, 2020, a consolidated EBITDA of not less than $9.5 million on a trailing twelve-months basis, and to report our compliance with such requirement on or before August 15, 2020. The Letter Agreement provides that such covenant will not be tested until August 15, 2020. Under the terms of the Letter Agreement we are not permitted to request any additional borrowings under the revolving line of credit under the credit agreement through August 15, 2020, and we will not be permitted to request any such additional borrowings thereafter unless we are in compliance with the credit agreement. The Letter Agreement also prohibits us from making any dividend or stock repurchase payments or other restricted payments through August 15, 2020, and we will be permitted to make restricted payments thereafter only in compliance with the credit agreement.

The description of the Letter Agreement is qualified in its entirety by reference to the full text of the Letter Agreement, a copy of which is attached hereto as Exhibit 10.3 and is incorporated herein by reference.

Contents

Item
6.

Exhibits

3A  Restated Articles of Incorporation of the Company and all amendments thereto, filed as Exhibit 3A to the Company’s Quarterly Report on Form10-Q for the quarter ended April 30, 2016 and incorporated by reference herein.
3B  By-laws of the Company as amended to date, filed as Exhibit 3B to the Company’s Annual Report on Form10-K/A for the fiscal year ended January 31, 2008 (File no.000-13200) and incorporated by reference herein.
10.1First Amendment to Credit Agreement dated as of March 24, 2021 among AstroNova, Inc. ANI ApS, TrojanLabel ApS and Bank of America, N.A., filed as Exhibit 10.34 to the Company’s Annual Report on Form 10-K for the period ended January 31, 2021 and incorporated by reference herein.
10.1Loan Agreement effective as of May 6, 2020, by and between Astronova, Inc. and Greenwood Credit Union.
10.2  Promissory NoteFirst Amendment to Open-End Mortgage Deed to Secure Present and Future Loans under Chapter 25 of Title 34 of the Rhode Island General Laws, Assignment of Leases and Rents, Security Agreement and Fixture Filing dated May 6, 2020, by and between Astronova, Inc. and Greenwood Credit Union.
10.3Letteras of Agreement dated June 22, 2020 betweenMarch 24, 2021 among AstroNova, Inc. and Bank of America, , N.A.N.A, filed as Exhibit 10.35 to the Company’s Annual Report on Form 10-K for the period ended January 31, 2021 and incorporated by reference herein.
31.1  Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.2002
31.2  Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.2002
32.1  Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.2002
32.2  Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.2002
101101.INS  The following materials from Registrant’s Quarterly Report onForm 10-Q for XBRL Instance Document—the period ended May 2, 2020, formattedinstance document does not appear in the Interactive Data File because its XBRL (eXtensible Business Reporting Language): (i)tags are embedded within the Condensed Consolidated Balance Sheets, (ii)Inline XBRL document
101.SCH            Inline XBRL Taxonomy Extension Schema Document
101.CAL            Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF            Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB            Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE            Inline XBRL Taxonomy Extension Presentation Linkbase Document
104        Cover Page Interactive Data File (embedded within the Condensed Consolidated Statements of Income, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statements of Shareholders’ Equity, (v) the Condensed Consolidated Statements of Cash Flows, and (vi) the Notes to the Condensed Consolidated Financial Statements. Filed electronically herein.Inline XBRL document)

32

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  
ASTRONOVA, INC.
INC.
(Registrant)
Date: June 26, 202010, 2021  By 

/s/ Gregory A. Woods

   Gregory A. Woods,
   President and Chief Executive Officer
   (Principal Executive Officer)
  By 

/s/ David S. Smith

   David S. Smith,
   Vice President, Chief Financial Officer and Treasurer (Principal
(Principal Accounting Officer and Principal Financial Officer)

35

33